Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value
44816559	b-peth	— (—)	12840	18373	100.00%
44816559	b-peth	umol/l (mg/l)	9207	16703	0.00%
44816559	b-peth	µmol/l (mg/l)	558	897	0.00%
44816559	b-peth	umol/l____ (mg/l)	355	592	0.00%
44816559	b-peth	UMOL/L (mg/l)	17	17	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other specified and unspecified personality disorders

759

1730

5.16

318.28

2.3

1.7

0.27

0.32

mg/l

1.40

344

846

Emotional disorders starting during childhood or adolecense, excluding more controls

363

11.38

317.24

2.1

1.3

0.19

0.20

mg/l

0.14

143

139

Intracranial injury

2645

11337

2.27

307.87

2.3

1.6

0.37

0.26

mg/l

16.47

1521

4965

Personality disorders

2576

6163

4.88

307.65

2.2

1.7

0.25

0.31

mg/l

6.48

1221

2941

Benzodiazepine use

5971

14193

3.02

307.65

2.1

1.6

0.30

mg/l

0.06

3045

6639

Codeine or tramadol medication

4974

13856

2.02

307.65

1.9

1.7

0.32

0.29

mg/l

2.36

2568

6391

Persons encountering health services in other circumstances

2133

7638

2.93

307.65

2.2

1.6

0.31

0.29

mg/l

0.61

1052

3520

Use of hypnotics and sedatives

5117

13000

2.35

307.65

2.0

1.7

0.32

0.31

mg/l

0.76

2749

6099

Mental and behavioural disorders due to psychoactive substance use

6107

10643

6.15

307.65

2.7

1.4

0.40

0.24

mg/l

72.64

4101

4524

Phobic anxiety disorders

1208

2460

5.70

307.65

2.1

1.7

0.26

0.30

mg/l

1.64

563

1159

Mood disorders

7572

11945

4.45

307.65

2.0

1.6

0.30

0.31

mg/l

1.17

3688

5720

Poisoning by drugs, medicaments and biological substances

2385

5221

5.42

307.65

2.5

1.7

0.31

0.30

mg/l

0.11

1413

2417

Implicit Sepsis, including avohilmo

3645

12280

2.21

307.65

2.1

1.7

0.37

0.30

mg/l

8.71

1851

5853

Disorders of adult personality and behaviour

2738

6600

4.84

307.65

2.2

1.7

0.25

0.31

mg/l

6.34

1291

3133

Viral hepatitis, IBD co-morbidity

756

827

12.17

307.65

2.9

1.7

0.26

0.28

mg/l

0.24

424

402

Other reaction to severe stress, and adjustment disorders

2132

6862

3.34

307.65

2.1

1.7

0.30

0.31

mg/l

0.42

992

3293

Unspecified mental disorder

2960

8934

3.67

307.65

2.1

1.8

0.23

0.32

mg/l

17.25

1403

4414

Fall on same level

5208

14606

1.97

307.65

2.1

1.7

0.35

0.27

mg/l

14.10

2923

6509

Psychiatric diseases

4878

6526

3.96

307.65

1.9

1.4

0.35

0.26

mg/l

15.45

2483

2870

Other disorders of fluid, electrolyte and acid-base balance

1398

4203

3.32

307.65

2.3

1.6

0.42

0.31

mg/l

8.54

801

1951

Specific personality disorders

2266

5193

5.13

307.65

2.2

1.7

0.24

0.31

mg/l

6.53

1073

2448

Anaemias

1342

1278

7.34

307.65

2.3

1.5

0.42

0.29

mg/l

6.91

664

614

Social phobias

822

1567

6.23

307.65

2.2

1.6

0.25

0.30

mg/l

1.68

387

730

Examination and observation for other reasons

2901

6383

2.69

307.65

2.1

1.6

0.32

mg/l

0.02

1420

3204

Alcohol use disorder, ICD-based

4401

8227

6.41

307.65

2.9

1.5

0.42

0.27

mg/l

51.74

3150

3759

Mental and behavioural disorders due to use of other stimulants, including caffeine

484

699

10.73

307.65

3.2

1.7

0.23

0.32

mg/l

2.60

278

354

Sleep disorders (combined)

4700

12073

2.10

307.65

1.8

1.7

0.28

0.31

mg/l

2.65

2227

5651

Alcohol use disorder, Swedish definition

5738

9257

6.67

307.65

2.8

1.4

0.42

0.23

mg/l

90.29

4007

4006

Hyperkinetic disorders, excluding more controls

1523

1318

13.36

307.65

2.0

1.3

0.17

0.22

mg/l

2.07

677

561

Mental and behavioural disorders due to opioids

618

874

10.67

307.65

3.1

1.7

0.23

0.31

mg/l

2.73

342

430

Post-traumatic stress disorder

749

1336

6.55

307.65

1.9

1.6

0.20

0.30

mg/l

4.71

314

580

Convulsions, not elsewhere classified

1535

4676

3.53

307.65

2.4

1.6

0.38

0.28

mg/l

9.59

918

2207

Hyperkinetic disorders

1529

3528

5.06

307.65

2.0

1.7

0.17

0.25

mg/l

8.71

680

1538

Alcohol withdrawal state with delirium

660

1288

6.39

307.65

3.2

1.8

0.50

0.31

mg/l

11.05

484

671

Other and unspecified mood [affective] disorders

771

1075

8.91

307.65

2.2

1.6

0.25

0.32

mg/l

1.67

404

506

Anxiety (asthma-related co-morbidities)

5025

6826

6.29

307.65

2.0

1.4

0.27

0.25

mg/l

1.60

2373

3034

Poisoning by medicine

2220

4732

5.62

307.65

2.5

1.7

0.31

0.30

mg/l

0.31

1328

2169

Acute alcohol intoxication, ICD10

2007

4445

5.40

307.65

2.9

1.7

0.43

0.29

mg/l

21.83

1495

2169

Injuries to the head

5311

15140

2.16

307.65

2.2

1.6

0.37

0.27

mg/l

25.61

3081

6623

Cirrhosis of liver, NAS

725

735

14.24

307.65

2.5

1.6

0.34

0.33

mg/l

0.04

301

349

Kela-code for severe mental illness

2655

7904

3.73

307.65

2.1

1.8

0.22

0.32

mg/l

20.48

1260

3947

Non-selective monoamine reuptake inhibitors

1478

4223

3.54

307.65

1.9

1.5

0.30

0.31

mg/l

0.15

671

1878

Implicit Sepsis

3292

11132

2.27

307.65

2.1

1.7

0.37

0.30

mg/l

7.96

1637

5322

Exposure to unspecified factor

4654

16193

2.03

307.65

2.0

1.7

0.34

0.29

mg/l

6.92

2506

7444

Alcohol abuse, main dg, excluding more controls

1570

1953

9.91

307.65

2.9

1.5

0.43

0.26

mg/l

21.71

1155

970

Use of disulfiram, acamprosate or naltrexone

1071

2014

7.00

307.65

3.5

1.8

0.40

0.34

mg/l

2.12

792

1076

Behavioural syndromes associated with physiological disturbances and physical factors

4718

14486

2.31

307.65

1.9

1.7

0.29

0.31

mg/l

1.56

2368

6866

Condition for Implicit Sepsis (Organ dysfunction codes)

3815

12539

2.19

307.65

2.1

1.7

0.37

0.29

mg/l

9.33

1946

5981

Intracranial trauma

2920

7972

2.59

307.65

2.3

1.7

0.37

0.28

mg/l

13.37

1679

3713

Persons encountering health services in other circumstances, wide

5346

12432

2.30

307.65

2.0

1.7

0.32

0.30

mg/l

1.98

2690

5963

Mental and behavioural disorders due to alcohol

5247

9277

6.34

307.65

2.8

1.4

0.42

0.24

mg/l

75.23

3728

4049

Hypothyroidism and >3 levothyroxin purchases

1117

1354

4.88

307.65

1.8

1.5

0.27

0.28

mg/l

0.22

467

652

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4811

12430

2.13

307.65

1.9

1.7

0.32

0.30

mg/l

1.38

2329

5963

General symptoms and signs

4715

11961

2.04

307.65

2.0

1.7

0.33

0.28

mg/l

6.21

2340

5726

Alcohol abuse, main dg

1570

3461

5.48

307.65

2.9

1.7

0.43

0.30

mg/l

12.97

1155

1727

Anxiety disorders

5933

12587

3.49

307.65

2.0

1.7

0.28

0.32

mg/l

3.55

2802

6171

KRA_PSY_EATING, excluding more controls

567

706

9.01

307.65

1.6

1.3

0.22

0.23

mg/l

0.20

212

257

Other antidepressants

6190

8270

4.10

307.65

2.0

1.5

0.31

0.29

mg/l

1.14

3167

3819

Mental and behavioural disorders due to sedatives or hypnotics

861

1384

8.32

307.65

2.9

1.7

0.28

0.32

mg/l

1.34

505

702

Nonorganic sleeping disorders

1454

4858

3.29

307.65

2.0

1.7

0.26

0.30

mg/l

2.27

658

2252

Substance abuse

5965

10502

6.18

307.65

2.7

1.4

0.40

0.24

mg/l

68.16

3997

4518

Substance use, excluding alcohol

2172

3748

7.11

307.65

2.7

1.4

0.29

0.23

mg/l

4.07

1241

1603

Other and unspecified nonorganic psychotic disorders

1866

4566

4.80

307.65

2.2

1.8

0.24

0.31

mg/l

7.32

902

2284

Problems related to lifestyle

1101

1990

6.74

307.65

2.7

1.7

0.36

0.30

mg/l

2.73

681

985

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1716

2367

9.46

307.65

2.8

1.6

0.48

0.33

mg/l

12.55

986

1194

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2428

3273

8.48

307.65

2.4

1.4

0.31

0.25

mg/l

4.14

1397

1447

Sleep disorders

4529

14247

2.29

307.65

1.9

1.7

0.29

0.31

mg/l

1.43

2288

6743

Mood [affective] disorders

7572

11942

4.46

307.65

2.0

1.6

0.30

0.31

mg/l

1.15

3687

5720

Suicide or other Intentional self-harm

2188

5352

4.74

307.65

2.5

1.7

0.31

0.30

mg/l

0.23

1316

2479

All anxiety disorders

5166

10131

4.41

307.65

2.0

1.7

0.27

0.32

mg/l

5.95

2434

4972

General examination and investigation of persons without complaint and reported diagnosis

3195

6406

2.72

307.65

2.1

1.6

0.28

0.32

mg/l

2.07

1578

3215

Persons encountering health services for specific procedures, not carried out

815

1780

5.46

307.65

2.5

1.7

0.36

0.29

mg/l

2.63

483

861

6192

9906

6.37

307.65

2.7

1.4

0.41

0.22

mg/l

106.99

4309

4136

Other anxiety disorders

4209

8093

5.02

307.65

2.0

1.7

0.27

0.31

mg/l

4.31

1973

3907

Any mental disorder

6088

7655

4.25

307.65

2.0

1.4

0.34

0.26

mg/l

19.35

3117

3364

Other viral hepatitis, including avohilmo

808

1574

6.72

307.65

2.9

1.8

0.26

0.32

mg/l

2.11

450

804

Depression or dysthymia

3590

3945

5.33

307.65

1.9

1.3

0.35

0.23

mg/l

20.12

1854

1658

Depression medications

2166

1486

8.10

307.65

2.0

1.5

0.30

0.28

mg/l

0.57

1065

728

Nonorganic sleeping disorders, excluding more controls

1454

2420

6.75

307.65

2.0

1.4

0.26

0.24

mg/l

0.35

658

1043

Opioids

4406

11257

2.09

307.65

1.9

1.7

0.30

0.28

mg/l

1.08

2253

5074

Oesophageal varices

492

616

10.97

307.65

3.1

1.7

0.37

0.35

mg/l

0.20

209

296

Diseases of liver

3264

6032

6.40

307.65

2.2

1.6

0.40

0.31

mg/l

9.40

1609

2988

Other viral hepatitis

755

1461

6.76

307.65

2.9

1.8

0.26

0.32

mg/l

1.67

421

756

Substance abuse, excluding more controls

5965

6530

9.04

307.65

2.7

1.4

0.40

0.26

mg/l

49.99

3997

3001

Persistent mood disorders

1207

2728

4.91

307.65

1.9

1.6

0.24

0.31

mg/l

4.06

520

1267

Fibrosis and cirrhosis of liver

891

993

11.97

307.65

2.3

1.5

0.34

0.33

mg/l

0.08

352

475

Alcoholic liver disease

1144

1567

9.54

307.65

3.3

1.6

0.51

0.34

mg/l

11.88

813

824

Codeine

4351

10950

2.23

307.65

1.9

1.7

0.32

0.29

mg/l

2.65

2262

4959

Concussion

2487

7845

2.58

307.65

2.2

1.7

0.37

0.28

mg/l

10.55

1404

3659

Hypothyroidism (congenital or acquired)

1130

1364

4.90

307.65

1.8

1.5

0.28

mg/l

0.01

469

658

Viral hepatitis, including avohilmo

835

1734

6.07

307.65

2.9

1.8

0.25

0.31

mg/l

2.31

463

880

Alcohol dependence

2732

4483

7.38

307.65

3.2

1.4

0.43

0.26

mg/l

38.36

1974

2028

Disturbance of activity and attention

1485

3179

5.50

307.65

2.0

1.7

0.16

0.26

mg/l

11.58

653

1387

Acute alcohol intoxication

2117

4433

5.49

307.65

2.8

1.4

0.42

0.25

mg/l

32.21

1547

1934

Selective serotonin reuptake inhibitors

5413

8280

3.61

307.65

2.0

1.5

0.31

0.29

mg/l

0.91

2724

3823

Nonalcoholic fatty liver disease

1011

1927

6.47

307.65

1.8

0.30

0.32

mg/l

0.60

472

964

Schizophrenia, schizotypal and delusional disorders

2411

7143

3.77

307.65

2.2

1.8

0.24

0.31

mg/l

10.17

1120

3572

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

4191

13353

2.21

307.65

2.1

1.7

0.36

0.29

mg/l

11.51

2118

6350

Tramadol

3878

9377

2.61

307.65

2.0

1.7

0.34

0.30

mg/l

3.14

1968

4316

Anxiety disorders, excluding more controls

5345

7234

5.14

307.65

2.0

1.4

0.29

0.26

mg/l

3.36

2556

3207

Personality disorders, excluding more controls

2576

3180

9.65

307.65

2.2

1.4

0.25

mg/l

0.25

1221

1433

Chronic viral hepatitis

691

1260

7.47

307.65

3.0

1.8

0.26

0.32

mg/l

1.64

394

658

Other diseases of liver

1532

3063

5.85

307.65

1.9

1.7

0.31

mg/l

0.10

684

1492

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2122

4951

4.31

307.65

2.0

1.7

0.19

0.26

mg/l

8.44

933

2229

Viral hepatitis

782

1628

6.05

307.65

2.9

1.8

0.26

0.32

mg/l

2.01

434

822

Bipolar affective disorders

1859

3067

7.26

307.65

2.2

1.6

0.23

0.30

mg/l

6.55

968

1478

Generalized anxiety disorder

1401

2883

5.57

307.65

1.8

1.6

0.22

0.30

mg/l

4.79

577

1289

Hypothyroidism, levothyroxine purchases

1117

1354

4.88

307.65

1.8

1.5

0.27

0.28

mg/l

0.22

467

652

Schizophrenia or delusion, excluding more controls

2410

3830

7.09

307.65

2.2

1.4

0.24

0.26

mg/l

0.73

1119

1769

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1753

3696

5.78

307.65

2.5

1.7

0.31

0.30

mg/l

0.18

1069

1698

Recurrent or chronic depression

2896

2922

7.65

307.65

1.9

1.3

0.30

0.23

mg/l

7.45

1389

1242

Neurotic, stress-related and somatoform disorders

5912

12539

3.51

307.65

2.0

1.7

0.28

0.32

mg/l

3.56

2791

6152

Antihypertensive medication - note that there are other indications

3173

7181

2.42

307.65

2.0

1.6

0.29

0.25

mg/l

2.33

1539

3150

Depression

7144

11731

4.48

307.65

2.0

1.6

0.30

0.31

mg/l

0.49

3474

5638

Assault

1295

3559

4.28

307.65

2.7

1.8

0.36

0.31

mg/l

3.10

866

1787

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2428

6592

4.17

307.65

2.4

1.7

0.31

0.29

mg/l

0.47

1397

2939

5958

9779

6.39

307.65

2.7

1.4

0.42

0.23

mg/l

103.04

4161

4132

Emotionally unstable personality disorder

1467

2573

7.20

307.65

2.2

1.7

0.24

0.29

mg/l

2.48

726

1166

Open wound of head

2557

10670

2.36

307.65

2.3

1.6

0.39

0.28

mg/l

19.45

1631

4929

Schizophrenia or delusion

2410

7133

3.78

307.65

2.2

1.8

0.24

0.31

mg/l

10.19

1119

3572

Mood disorders, excluding more controls

6754

7618

5.74

307.65

2.0

1.4

0.30

0.26

mg/l

6.77

3341

3353

Panic disorder

1202

2568

5.35

307.65

2.2

1.6

0.26

0.30

mg/l

1.28

598

1174

Insomnia

4458

14457

2.24

307.65

1.9

1.7

0.29

0.31

mg/l

1.28

2253

6801

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

1081

1690

9.10

307.65

3.2

1.7

0.26

0.29

mg/l

0.81

640

858

Mental and behavioural disorders due to alcohol, excluding acute intoxication

4707

8632

6.46

307.65

2.8

1.5

0.42

0.26

mg/l

61.40

3352

3904

Mental and behavioural disorders due to cannabinoids

479

782

9.00

303.52

2.9

1.7

0.24

0.30

mg/l

1.53

285

391

Ascites

533

923

6.68

302.53

3.2

1.6

0.39

0.33

mg/l

1.03

253

447

896

2386

4.15

299.54

2.0

1.7

0.26

0.28

mg/l

0.64

427

1075

Psychotic depression

378

453

9.45

297.66

2.0

1.3

0.25

0.24

mg/l

0.05

173

203

Mixed and other personality disorders

704

1599

5.24

297.56

2.3

1.7

0.28

0.33

mg/l

1.29

340

802

Medical observation and evaluation for suspected diseases and conditions

2792

6406

2.31

296.83

1.9

1.6

0.29

0.32

mg/l

1.27

1318

3215

Metabolic disorders

3915

12284

1.97

292.47

1.9

1.7

0.36

0.30

mg/l

7.91

1971

5969

Malaise and fatigue

2174

7318

2.43

289.43

1.9

1.6

0.35

0.29

mg/l

3.91

936

3374

Dental caries

1288

4165

3.11

280.83

2.3

1.6

0.31

0.33

mg/l

0.77

627

2096

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

630

1385

5.48

278.15

2.6

1.7

0.29

mg/l

0.01

392

662

Any gastric operation

3436

8627

2.06

276.95

1.9

1.6

0.30

0.27

mg/l

2.07

1583

4146

GASTRO-related operations

3436

8627

2.06

276.95

1.9

1.6

0.30

0.27

mg/l

2.07

1583

4146

Other nutritional deficiencies

3037

14140

2.04

268.28

1.7

1.8

0.29

0.31

mg/l

0.99

1328

6773

Endocrine, nutritional and metabolic diseases

3511

9088

2.01

265.78

1.8

0.30

0.28

mg/l

1.27

1621

4502

Falls/tendency to fall

4449

12361

1.85

265.29

2.0

1.6

0.35

0.27

mg/l

15.80

2418

5386

Implicit bacterial Sepsis, including avohilmo

1800

6170

2.53

263.49

2.1

1.6

0.38

0.30

mg/l

5.20

903

2917

Assault by bodily force

755

1991

4.51

263.30

2.7

1.9

0.36

0.30

mg/l

1.99

525

989

Other and unspecified anaemias

1601

5957

2.63

261.04

1.9

1.6

0.37

0.31

mg/l

3.85

784

2714

Mixed disorders of conduct and emotions, excluding more controls

246

199

15.87

259.91

2.2

1.3

0.25

0.20

mg/l

0.53

104

Other anaemias

1610

6021

2.61

257.98

1.9

1.6

0.37

0.30

mg/l

4.03

786

2749

Symptoms and signs involving cognition, perception, emotional state and behaviour

3992

14768

1.86

256.49

1.9

1.7

0.31

0.30

mg/l

0.45

1860

7159

Other symptoms and signs involving cognitive functions and awareness

1851

7000

2.44

254.64

1.9

1.6

0.32

0.31

mg/l

0.30

882

3357

Other soft tissue disorders, not elsewhere classified

4024

12632

1.87

252.23

1.9

1.7

0.29

0.30

mg/l

0.28

1839

6050

Obsessive-compulsive disorder

547

1146

5.49

251.94

2.0

1.6

0.23

0.29

mg/l

1.34

189

521

Implicit bacterial Sepsis

1609

5545

2.60

250.00

2.2

1.6

0.38

0.30

mg/l

4.47

806

2622

Any reimbursement code in KELA

2724

6519

2.17

249.21

1.9

1.7

0.28

0.30

mg/l

0.68

1288

3094

Superficial injury of head

1201

4274

2.99

247.41

2.3

1.6

0.39

0.27

mg/l

10.15

721

1846

Caries of dentine

1136

3769

3.10

247.39

2.3

1.7

0.32

0.33

mg/l

0.27

552

1903

Transport accidents

2055

7691

2.31

246.88

2.3

1.5

0.31

0.26

mg/l

4.42

1139

3196

Obesity and other hyperalimentation

2845

13749

2.02

246.58

1.7

1.8

0.28

0.31

mg/l

2.90

1233

6588

Obesity

2834

13721

2.02

245.44

1.7

1.8

0.28

0.31

mg/l

2.86

1229

6570

Aplastic and other anaemias

1681

6469

2.47

239.91

1.9

1.6

0.37

0.30

mg/l

4.17

816

2985

Parasetamol

3217

8384

2.00

239.81

1.9

1.7

0.31

0.29

mg/l

0.98

1622

3880

Bacterial Sepsis

1821

6536

2.40

237.00

2.1

1.6

0.37

0.30

mg/l

5.17

912

3081

Diseases of oesophagus, stomach and duodenum

4261

14438

1.79

236.10

2.0

1.7

0.36

0.29

mg/l

9.20

2102

6928

Acute and transient psychotic disorders

795

2312

3.86

235.66

2.3

1.8

0.24

0.32

mg/l

4.33

375

1191

Agoraphobia

351

525

8.47

234.28

2.1

1.6

0.25

0.30

mg/l

0.75

166

257

Other diseases of the digestive system

1326

5116

2.73

232.81

2.4

1.6

0.43

0.30

mg/l

10.22

743

2404

GI-bleeding

1321

5123

2.71

229.38

2.4

1.6

0.43

0.30

mg/l

9.73

749

2425

Acute pancreatitis

994

3339

3.20

228.92

2.3

1.7

0.46

0.31

mg/l

9.53

538

1720

Speech and linguistic disorders, excluding more controls

445

770

5.94

227.95

2.0

1.3

0.23

0.22

mg/l

0.18

185

336

Type 2 diabetes, definitions combined, including avohilmo

3685

11851

1.85

225.53

1.8

0.33

0.31

mg/l

0.80

1730

5793

Type 2 diabetes

3854

12597

1.82

224.66

1.8

0.33

0.31

mg/l

0.93

1790

6130

Type 2 diabetes, definitions combined

3654

11824

1.85

224.06

1.8

1.7

0.33

0.31

mg/l

0.71

1702

5780

Type 2 diabetes, strict (exclude DM1)

3663

11875

1.84

223.30

1.8

0.33

0.32

mg/l

0.59

1703

5806

Hypertensive diseases (excluding secondary)

2361

6589

2.17

223.24

2.0

1.8

0.37

0.29

mg/l

7.94

1250

3216

Hypo-osmolality and hyponatraemia

743

2114

3.72

219.36

2.3

1.6

0.42

0.31

mg/l

4.76

430

943

Schizophrenia

1004

3513

3.14

217.64

2.0

1.8

0.24

0.32

mg/l

5.90

419

1866

Heart failure, not strict

2690

9294

2.01

217.13

1.9

1.7

0.35

0.32

mg/l

1.77

1320

4631

Neurological diseases

3473

9575

1.87

213.98

1.8

1.7

0.30

0.29

mg/l

0.10

1600

4589

Type 2 diabetes, wide definition

2814

9271

1.97

212.99

1.8

0.33

0.32

mg/l

0.21

1300

4650

Neurological diseases, wide definition

1443

2779

2.73

212.74

1.9

1.6

0.30

0.25

mg/l

2.39

686

1231

Acute renal failure

963

3318

3.09

210.76

2.1

1.6

0.42

0.32

mg/l

4.99

532

1596

Pain in limb

3419

12160

1.84

209.95

1.9

1.7

0.31

0.30

mg/l

0.68

1573

5804

Diabetes, varying definitions

4017

13578

1.76

209.89

1.8

0.32

0.30

mg/l

1.42

1881

6580

Dorsalgia

4094

12644

1.76

209.82

1.9

1.7

0.29

0.30

mg/l

0.50

1982

5982

Diabetes mellitus

4027

13601

1.75

207.87

1.8

0.32

0.30

mg/l

1.19

1884

6585

Hypertension, essential

3079

9394

1.91

206.74

1.9

1.8

0.36

0.31

mg/l

4.93

1630

4566

Acute pancreatitis (for exclusion)

994

3535

3.02

206.71

2.3

1.7

0.46

0.32

mg/l

9.29

538

1768

Chronic pancreatitis

714

2102

3.75

206.33

2.4

1.7

0.53

0.32

mg/l

12.11

425

1117

Chronic apical periodontitis

4427

14907

1.71

206.24

1.9

1.7

0.31

0.30

mg/l

0.99

2163

7052

Headache

2691

11003

1.95

205.07

1.8

1.6

0.28

0.29

mg/l

0.43

1226

5193

Sleep apnoea

3664

13283

1.79

204.86

1.7

1.8

0.28

0.32

mg/l

3.92

1742

6564

Diseases of the digestive system

1779

8201

2.24

204.45

2.2

1.7

0.41

0.30

mg/l

9.71

933

3805

Low back pain

3235

12174

1.85

203.96

1.9

1.7

0.30

mg/l

0.15

1553

5756

Dental pulpitis, including avohilmo

4028

15314

1.73

202.72

2.0

1.7

0.28

0.31

mg/l

2.18

1967

7394

Alcohol-induced chronic pancreatitis

507

1227

4.90

197.98

2.7

1.8

0.56

0.32

mg/l

11.14

335

655

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3756

14856

1.75

197.85

1.9

1.7

0.36

0.30

mg/l

7.12

1745

7175

Hepatic failure, not elsewhere classified

316

503

7.69

197.70

3.2

1.6

0.41

0.34

mg/l

0.81

153

242

Obesity due to excess calories

2117

10671

2.07

197.04

1.7

1.8

0.28

0.31

mg/l

1.81

922

5081

Other external causes of accidental injury

2988

8044

1.91

196.11

1.9

1.5

0.33

0.26

mg/l

7.81

1504

3324

Abnormal findings on examination of blood, without diagnosis

1887

8220

2.16

195.03

1.7

0.29

0.32

mg/l

1.64

844

4097

Diseases of pulp and periapical tissues, including avohilmo

3936

11964

1.74

194.24

1.8

1.6

0.30

0.29

mg/l

0.72

1863

5506

Symptoms and signs involving the digestive system and abdomen

3938

11581

1.75

194.04

1.9

1.7

0.32

0.29

mg/l

1.92

1876

5757

Chronic periodontitis, complicated

2210

11052

2.02

193.65

2.0

1.7

0.34

0.32

mg/l

0.80

1266

5385

Other bacterial diseases, including avohilmo

3972

14841

1.71

191.64

2.0

1.7

0.34

0.30

mg/l

4.39

2024

7096

Injuries to the thorax

1924

9448

2.12

191.57

2.5

1.7

0.38

0.31

mg/l

5.99

1117

4582

Heart failure and antihypertensive medication

920

1991

3.15

188.93

1.8

1.6

0.37

0.31

mg/l

1.89

491

955

Episodal and paroxysmal disorders

4205

12861

1.70

188.05

1.8

0.28

0.30

mg/l

2.08

1897

6231

Accidents

2952

8044

1.89

186.67

1.9

1.5

0.32

0.26

mg/l

6.62

1483

3324

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3981

15439

1.69

185.73

1.9

1.7

0.33

0.29

mg/l

2.68

1921

7371

Hypertension

3071

9675

1.84

184.75

1.9

1.8

0.36

0.30

mg/l

5.05

1618

4701

Hypertensive diseases

3073

9685

1.84

184.74

1.9

1.8

0.36

0.30

mg/l

5.03

1620

4704

External causes of morbidity and mortality

2387

6093

2.02

182.90

1.8

1.4

0.32

0.25

mg/l

5.50

1170

2431

Hypokalaemia

569

1551

3.96

182.58

2.5

1.6

0.43

0.30

mg/l

4.29

333

688

Schizoaffective disorder

544

1470

4.22

180.82

1.9

1.8

0.21

0.33

mg/l

6.60

234

753

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

3508

12220

1.75

179.48

1.8

0.32

0.31

mg/l

0.25

1676

6044

Asthma, excluding more controls

2946

8359

1.86

179.01

1.8

1.7

0.30

mg/l

0.07

1420

3994

Other (not insulin) diabetes medications

3608

12554

1.73

177.82

1.8

1.7

0.32

mg/l

0.04

1664

6145

Delirium, not induced by alcohol and other psychoactive substances

542

1451

4.00

177.37

2.4

1.6

0.36

0.30

mg/l

1.64

273

649

Chronic periodontitis, including avohilmo

3761

14544

1.69

174.05

2.0

1.7

0.32

0.31

mg/l

0.99

2025

6927

Periodontitis

3766

14558

1.69

173.72

1.9

1.7

0.33

0.31

mg/l

1.02

2025

6936

Bleeding

3004

12074

1.79

173.45

2.1

1.7

0.39

0.30

mg/l

14.31

1647

5796

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1388

6202

2.34

172.74

2.0

1.7

0.26

0.28

mg/l

0.81

674

2679

Fracture of skull and facial bones

1087

4428

2.61

172.27

2.4

1.7

0.39

0.28

mg/l

7.83

688

2064

Injuries to the wrist and hand

3993

16369

1.66

172.16

2.1

1.7

0.32

0.29

mg/l

2.89

2172

7475

Sleep apnoea, including avohilmo

3755

13760

1.69

171.86

1.7

1.8

0.28

0.32

mg/l

5.02

1758

6747

Renal failure

1612

6498

2.19

171.12

2.0

1.7

0.38

0.31

mg/l

3.97

810

3125

Other bacterial diseases

3553

14142

1.71

170.92

2.0

1.7

0.34

0.31

mg/l

2.32

1818

6852

Mental disorders, not otherwise specified

560

1600

3.94

170.75

2.2

1.7

0.27

0.32

mg/l

1.14

262

757

Lower back pain or/and sciatica

4172

16200

1.64

170.14

1.9

1.7

0.30

mg/l

0.33

2018

7717

Gastrointestinal diseases

2384

6261

1.96

169.09

1.8

1.7

0.30

0.26

mg/l

1.94

1111

3001

Diabetes medication

3933

14121

1.66

168.81

1.8

0.31

mg/l

0.30

1825

6851

Monoamine oxidase A inhibitors

501

1320

4.08

168.56

1.8

1.5

0.25

0.28

mg/l

0.62

240

608

Pain in throat and chest

3380

11850

1.73

167.82

1.9

1.8

0.33

0.29

mg/l

3.12

1623

5767

Other dorsopathies, not elsewhere classified

3974

12681

1.67

166.67

1.9

1.7

0.30

mg/l

0.03

1900

5998

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1502

3334

2.33

164.08

1.9

1.7

0.32

0.27

mg/l

2.12

739

1650

Asthma

2984

8773

1.80

163.97

1.8

1.7

0.30

0.31

mg/l

0.19

1437

4194

Disorders of lipoprotein metabolism and other lipidaemias

2884

10064

1.79

160.68

1.7

1.8

0.33

0.31

mg/l

0.87

1404

5019

Persons encountering health services for specific procedures and health care

4196

15715

1.61

158.66

2.0

1.7

0.31

0.30

mg/l

0.75

2010

7541

Nutritional anaemias

1679

7981

2.07

158.09

2.0

1.6

0.37

0.29

mg/l

5.72

771

3581

Abdominal and pelvic pain

3764

11581

1.67

157.98

1.9

1.7

0.31

0.29

mg/l

0.63

1798

5757

Continuous positive airway pressure

587

1440

3.54

157.48

1.8

1.4

0.28

0.25

mg/l

0.56

262

691

Pain, not elsewhere classified

1155

5025

2.40

156.29

1.9

1.6

0.32

0.29

mg/l

0.77

513

2291

Diabetes, insulin treatment (Kela reimbursement)

3653

13414

1.66

155.04

1.8

0.32

0.31

mg/l

0.16

1742

6610

Implicit viral Sepsis, including avohilmo

1139

4931

2.40

154.82

2.1

1.6

0.31

0.29

mg/l

0.81

542

2227

Biguanides

3420

12574

1.68

153.30

1.8

0.32

mg/l

0.12

1554

6176

Fracture of lower leg, including ankle

2155

11625

1.88

152.94

2.1

1.7

0.36

0.30

mg/l

5.83

1286

5460

Certain infectious and parasitic diseases

3633

11168

1.67

151.46

1.8

1.6

0.31

0.29

mg/l

0.66

1730

5288

Disorders of gallbladder, biliary tract and pancreas

3481

13317

1.66

151.28

1.9

1.7

0.36

0.31

mg/l

5.23

1477

6612

Pain in joint

2286

7670

1.88

150.77

1.8

1.7

0.28

0.31

mg/l

1.23

1069

3784

Pain (limb, back, neck, head abdominally)

2724

7745

1.81

150.67

1.9

1.7

0.31

mg/l

0.08

1318

3826

Iron deficiency anaemia

1481

7082

2.12

149.38

2.0

1.6

0.37

0.29

mg/l

5.23

671

3141

Obesity, other/unspecified

1467

7175

2.13

148.71

1.7

0.28

0.32

mg/l

1.79

608

3393

Chronic hepatitis, not elsewhere classified

279

520

6.47

148.62

2.0

1.6

0.28

0.31

mg/l

0.23

248

Asthma, unspecified (mode), excluding more controls

1985

7527

1.94

148.47

1.7

0.32

0.31

mg/l

0.41

958

3557

Explicit Sepsis, including avohilmo

1557

6987

2.08

148.36

2.1

1.6

0.34

0.29

mg/l

2.62

787

3232

Injuries to the ankle and foot

3068

15945

1.69

148.25

2.0

1.8

0.31

0.30

mg/l

0.38

1568

7602

Exposure to other specified factors

3253

17247

1.66

147.96

2.1

1.7

0.32

0.30

mg/l

2.15

1753

8093

Persons encountering health services for examination and investigation

2345

6406

1.88

147.80

1.9

1.6

0.31

0.32

mg/l

0.18

1149

3215

Explicit Sepsis

1521

6813

2.10

147.68

2.1

1.6

0.34

0.29

mg/l

2.64

764

3156

Cardiovascular diseases (excluding rheumatic etc)

2788

9283

1.77

147.13

2.0

1.7

0.33

0.26

mg/l

7.54

1359

4305

Symptoms and signs involving the circulatory and respiratory systems

3881

12250

1.62

145.96

1.9

1.7

0.32

0.29

mg/l

2.14

1833

5910

Oedema, not elsewhere classified

1138

4930

2.34

145.75

1.9

1.5

0.33

0.29

mg/l

1.49

521

2256

Behavioural disorders, excluding more controls

178

208

10.33

144.50

2.2

1.5

0.28

0.22

mg/l

0.60

107

Infections of the skin and subcutaneous tissue

2478

14256

1.76

142.59

2.0

1.8

0.30

mg/l

0.28

1229

6991

Asthma (mode)

2889

8943

1.74

142.10

1.7

0.30

0.31

mg/l

0.36

1366

4293

Cardiovascular diseases

2746

8493

1.77

141.85

1.9

1.7

0.32

0.26

mg/l

5.68

1329

3918

Intentional self-harm by sharp object

296

618

6.17

141.74

2.6

1.6

0.29

0.26

mg/l

0.39

180

279

Renal tubulo-interstitial diseases

3099

13926

1.67

140.43

1.9

1.7

0.35

0.30

mg/l

4.34

1490

6478

Maltreatment syndromes

455

1305

4.08

140.36

2.7

1.8

0.32

0.30

mg/l

0.29

292

630

Intestinal infectious diseases, including avohilmo, including avohilmo

4198

15228

1.57

139.69

1.8

1.7

0.33

0.29

mg/l

3.42

2007

7265

Other gastritis (incl. Duodenitis)

838

3323

2.65

139.34

2.2

1.6

0.37

0.31

mg/l

2.14

411

1553

Asthma, unspecified (mode)

2008

7895

1.89

138.09

1.7

0.32

0.31

mg/l

0.24

966

3725

Injuries to the knee and lower leg

4411

15730

1.55

137.79

1.9

1.7

0.33

0.29

mg/l

5.12

2285

7200

Abnormalities of breathing

3412

12179

1.64

137.41

1.8

1.7

0.31

0.29

mg/l

1.05

1603

5867

Dissociative [conversion] disorders

271

527

5.92

136.20

2.0

1.5

0.22

0.29

mg/l

1.05

235

Special screening examination for infectious and parasitic diseases

1229

4134

2.26

136.07

1.8

1.7

0.28

0.32

mg/l

1.10

595

2080

Other diseases of intestines

4077

14825

1.56

134.69

1.8

0.31

0.30

mg/l

0.77

1952

7149

Other and unspecified iron deficiency

1201

5627

2.21

134.58

1.9

1.6

0.37

0.29

mg/l

3.72

530

2458

Alcohol-induced acute pancreatitis

316

720

5.35

134.50

3.0

1.8

0.56

0.33

mg/l

7.75

232

391

Other/unspecified dorsalgia

1409

6933

2.08

134.38

1.9

1.7

0.29

0.31

mg/l

1.15

664

3218

Wide developmental disorders, excluding more controls

208

305

7.52

133.77

1.6

1.4

0.15

0.24

mg/l

1.80

146

Other symptoms and signs involving general sensations and perceptions

289

611

5.44

132.13

2.4

1.7

0.32

0.29

mg/l

0.45

158

273

Emotional disorders and disorders of social functioning with onset specific to childhood

394

1033

4.26

132.03

2.0

1.6

0.19

0.20

mg/l

0.33

156

403

Erysipelas, including avohilmo

2617

11578

1.72

131.95

2.0

1.7

0.34

0.31

mg/l

1.42

1376

5701

Manic episode

242

446

6.44

129.99

2.5

1.6

0.20

0.35

mg/l

4.06

136

219

Unspecified fall

1938

10634

1.84

129.98

2.1

1.7

0.38

0.29

mg/l

9.10

1096

4896

Dorsopathies

3878

12716

1.58

129.94

1.9

1.7

0.30

mg/l

0.14

1872

6010

Fracture of rib(s), sternum and thoracic spine

1188

5649

2.19

129.55

2.5

1.7

0.41

0.32

mg/l

5.16

711

2765

Gout

967

3589

2.40

128.41

1.8

1.7

0.35

0.32

mg/l

0.63

558

1781

Septicaemia

1429

6591

2.04

128.41

2.1

1.6

0.34

0.31

mg/l

1.55

722

3106

Other disorders starting during childhood or adolecense, excluding more controls

238

402

6.17

128.15

1.9

1.4

0.18

0.21

mg/l

0.38

100

165

Follow-up examination after treatment for conditions other than malignant neoplasms

1524

5141

2.03

127.78

2.0

1.6

0.30

0.31

mg/l

0.24

737

2470

Syncope and collapse

1523

6580

1.99

125.85

2.0

1.6

0.37

0.29

mg/l

5.72

781

3048

Pure hypercholesterolaemia

2448

9153

1.74

125.76

1.7

1.8

0.32

0.31

mg/l

0.52

1174

4563

Symptoms and signs involving the nervous and musculoskeletal systems

2039

11687

1.79

125.62

1.8

1.7

0.32

0.30

mg/l

0.68

941

5475

Certain infectious and parasitic diseases, including avohilmo

2522

7416

1.74

124.06

1.8

1.7

0.30

mg/l

0.04

1185

3553

Injury, poisoning and certain other consequences of external causes

1809

4811

1.93

123.39

1.7

1.4

0.31

0.24

mg/l

4.89

875

1874

Nausea and vomiting

986

4311

2.31

123.31

2.0

1.6

0.37

0.28

mg/l

3.53

454

1936

Eating disorder

569

1993

3.13

123.09

1.6

0.22

0.23

mg/l

0.16

213

787

Cerebrovascular diseases (FINNGEN)

1156

3795

2.21

121.40

1.9

1.7

0.36

0.30

mg/l

2.93

623

1891

Other septicaemia

1253

5832

2.09

121.36

2.2

1.6

0.34

0.31

mg/l

1.09

639

2722

Atrial fibrillation and flutter with reimbursement

899

2365

2.49

119.91

1.9

1.7

0.39

0.30

mg/l

4.93

495

1190

Hernia of abdominal wall, postoperative

679

2595

2.71

119.52

2.1

1.6

0.36

0.30

mg/l

1.41

341

1305

3202

11911

1.60

119.36

2.0

1.7

0.33

0.29

mg/l

2.36

1561

5562

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3202

11911

1.60

119.36

2.0

1.7

0.33

0.29

mg/l

2.36

1561

5562

Other septicaemia, including avohilmo

1278

5999

2.06

119.28

2.2

1.6

0.34

0.31

mg/l

1.15

654

2797

Other special examinations and investigations of persons without complaint or reported diagnosis

2210

6406

1.79

119.00

1.8

1.6

0.31

0.32

mg/l

0.20

1068

3215

Other and unspecified effects of external causes

1254

6295

2.09

118.94

2.1

1.7

0.33

0.30

mg/l

1.50

648

2906

Hepatocellular carcinoma, including Hilmo

218

396

6.51

118.82

3.1

1.6

0.27

0.36

mg/l

1.25

187

Abnormal serum enzyme levels

1131

5264

2.16

118.22

1.5

1.7

0.27

0.33

mg/l

2.24

483

2705

Poisoning by narcotics and psychodysleptics [hallucinogens]

203

359

7.68

117.49

3.3

1.7

0.22

0.26

mg/l

0.50

122

172

Gastroduodenal ulcer

808

3396

2.46

116.87

2.3

1.5

0.42

0.30

mg/l

6.29

444

1577

All kidney diseases

3541

15656

1.54

115.31

1.9

1.7

0.34

0.30

mg/l

3.41

1679

7464

Other eating disorders

353

963

4.12

115.27

1.6

0.20

0.23

mg/l

0.55

136

384

Intestinal infectious diseases

3484

17131

1.54

114.49

1.9

1.7

0.32

0.30

mg/l

1.25

1616

8209

Primary biliary cholangitis, wide definition

177

272

7.83

114.21

1.9

1.8

0.24

0.37

mg/l

1.22

131

Fever of other and unknown origin

1934

9669

1.77

113.29

1.9

1.6

0.30

0.28

mg/l

0.67

841

4565

Gingivitis and periodontal diseases

3361

11236

1.57

113.14

1.8

1.7

0.31

mg/l

0.02

1621

5329

Gout, FINNGEN

967

4438

2.25

112.94

1.8

1.7

0.35

0.32

mg/l

0.77

558

2174

Other inflammatory liver diseases

347

946

4.05

112.68

2.0

1.6

0.33

0.31

mg/l

0.26

144

449

Injuries to the abdomen, lower back, lumbar spine and pelvis

1506

8031

1.91

112.64

2.2

1.7

0.31

0.30

mg/l

0.37

822

3730

Gout, idiopatic and unspecified

874

3889

2.35

112.54

1.8

1.7

0.35

0.32

mg/l

0.87

516

1888

Sciatica+with lumbago

1869

9498

1.79

112.50

1.9

1.7

0.29

0.32

mg/l

1.08

919

4587

Soft tissue disorders

3759

12808

1.53

111.64

1.9

1.7

0.30

mg/l

0.26

1793

6139

Autoimmune hepatitis, wide definition

291

707

4.65

111.55

2.0

1.8

0.31

0.33

mg/l

0.26

119

356

Gastro-oesophageal reflux disease

2305

11806

1.68

111.45

1.8

1.7

0.35

0.30

mg/l

2.82

1112

5700

Constipation

2975

12918

1.59

110.67

1.9

1.7

0.28

0.31

mg/l

2.20

1243

6288

Obesity related asthma

1340

7063

1.97

109.56

1.8

1.7

0.30

0.32

mg/l

0.64

652

3423

Polyneuropathies and other disorders of the peripheral nervous system

818

3588

2.39

109.33

1.9

1.7

0.39

0.32

mg/l

2.47

412

1739

Factors influencing health status and contact with health services

1074

2461

2.25

109.18

1.8

1.6

0.33

0.32

mg/l

0.14

558

1284

Eating disorders

601

2304

2.81

108.90

1.7

1.6

0.22

0.25

mg/l

0.56

228

942

Intentional self-harm by unspecified means

179

303

8.28

108.89

2.6

1.7

0.34

0.25

mg/l

1.02

112

134

Toxic effects of substances chiefly nonmedicinal as to source

627

2475

2.74

107.61

2.4

1.7

0.36

0.31

mg/l

1.35

388

1195

Erysipelas

1902

9575

1.76

107.07

2.0

1.7

0.33

0.31

mg/l

0.71

999

4768

Other CVD (FINNGEN)

443

1054

3.39

106.96

2.0

1.6

0.42

0.29

mg/l

3.61

208

470

Atrial fibrillation and flutter

1131

3538

2.13

106.76

2.0

1.8

0.42

0.30

mg/l

7.12

621

1818

Asthma, including avohilmo

4273

16271

1.47

106.32

1.8

0.30

mg/l

0.00

2034

7768

Symptoms and signs concerning food and fluid intake

456

1520

3.18

105.76

1.9

1.5

0.31

0.26

mg/l

0.96

192

673

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1637

5695

1.86

105.38

2.2

1.7

0.35

0.29

mg/l

3.95

790

2732

Asthma (only as main-diagnosis), excluding more controls

2463

8359

1.66

105.22

1.8

1.7

0.29

0.30

mg/l

0.44

1164

3994

Influenza and pneumonia

3892

16432

1.49

104.75

2.0

1.7

0.32

0.29

mg/l

2.40

1944

7778

Diarrhoea and gastroenteritis of presumed infectious origin

2660

15207

1.60

104.51

2.0

1.7

0.32

0.30

mg/l

1.49

1261

7325

Exclusions for E4_PCOS_CONSORTIUM

2531

9854

1.64

104.35

1.9

1.7

0.25

0.30

mg/l

3.52

1091

4354

Excluding asthma or asthma-COPD overlap

2799

8867

1.61

103.69

1.8

1.7

0.31

mg/l

0.02

1380

4242

Cutaneous abscess, furuncle and carbuncle

1147

5857

2.05

103.63

2.1

1.8

0.30

0.31

mg/l

0.41

579

2877

Alcohol abuse counselling and surveillance

192

365

7.07

103.04

2.5

1.7

0.44

0.32

mg/l

1.75

146

186

Care involving use of rehabilitation procedures

2240

12456

1.65

101.99

1.9

1.7

0.30

0.31

mg/l

0.54

1042

6040

Missing teeth due to accident, extraction or parodontitis

1993

10689

1.71

101.79

1.9

1.7

0.33

0.32

mg/l

0.63

949

5175

Early onset COPD, excluding more controls

754

3286

2.39

101.75

2.1

1.7

0.38

0.33

mg/l

1.33

434

1651

All pneumoniae

3704

16441

1.49

101.44

2.0

1.7

0.32

0.30

mg/l

2.09

1868

7815

Somatoform disorder

621

2489

2.62

101.33

1.8

1.6

0.29

0.31

mg/l

0.33

232

1146

Pneumonias (Asthma/COPD co-morbidities)

3678

16411

1.49

100.85

2.0

1.7

0.33

0.30

mg/l

2.41

1861

7808

Chronic lower respiratory diseases

4350

16045

1.45

100.26

1.8

0.30

mg/l

0.01

2115

7623

Other pulmonary diagnosis

2780

8867

1.60

100.09

1.9

1.7

0.31

mg/l

0.02

1358

4242

Traumatic subdural haemorrhage

424

1296

3.19

99.55

2.5

1.6

0.44

0.29

mg/l

4.48

276

572

Other heart diseases

1820

6875

1.77

99.36

2.0

1.8

0.38

0.28

mg/l

8.96

932

3312

Other and unspecified polyneuropathies, also in other diseases

701

3001

2.45

99.16

1.7

1.6

0.39

0.32

mg/l

1.65

342

1446

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

260

632

4.55

98.91

2.8

1.5

0.26

0.34

mg/l

1.46

285

Infections, IBD-co-morbidities

545

1391

2.86

98.54

2.1

1.6

0.36

0.28

mg/l

2.06

260

636

Other chronic obstructive pulmonary disease, including avohilmo

1592

7417

1.81

98.27

1.9

1.6

0.35

0.32

mg/l

1.77

883

3548

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3575

16313

1.49

96.88

2.0

1.7

0.33

0.30

mg/l

2.32

1822

7756

Gastric ulcer

560

2177

2.68

96.75

2.4

1.5

0.40

0.29

mg/l

4.15

304

988

Emotional disorders starting during childhood or adolescence

365

1136

3.61

96.57

2.1

1.6

0.19

mg/l

0.10

144

461

Asthma (only as main-diagnosis)

2492

8773

1.62

96.26

1.8

1.7

0.29

0.31

mg/l

0.68

1180

4194

Caries of dentine, including avohilmo

2386

7566

1.64

95.68

1.7

1.6

0.32

0.31

mg/l

0.40

1147

3586

Asthma-related infections

2096

12695

1.65

94.88

1.8

0.30

mg/l

0.06

992

5931

Asthma, hospital admission 2, infections

2096

12695

1.65

94.88

1.8

0.30

mg/l

0.06

992

5931

Autoimmune diseases

4029

14248

1.46

94.82

1.7

1.8

0.29

0.30

mg/l

0.45

1847

7012

Gout, strict definition

642

2697

2.50

94.70

1.7

1.6

0.33

0.31

mg/l

0.35

381

1277

Organic, including symptomatic, mental disorders

1396

5366

1.87

94.49

1.9

1.6

0.31

0.30

mg/l

0.25

664

2446

Hypothyroidism, drug reimbursement

367

748

3.54

94.32

1.5

0.28

0.31

mg/l

0.44

151

354

Chronic gastritis

758

3412

2.29

94.19

1.7

1.5

0.36

0.29

mg/l

2.12

325

1519

Disease of hard tissues of teeth, NOS

1676

4981

1.80

93.74

1.8

1.6

0.30

0.33

mg/l

1.08

789

2417

Mixed disorders of conduct and emotions

246

615

4.93

93.68

2.2

1.7

0.25

0.22

mg/l

0.27

104

254

COPD differential diagnosis

2762

8946

1.58

93.16

1.8

1.7

0.31

mg/l

0.09

1348

4294

Other headache syndromes

1443

8138

1.82

93.13

1.8

1.7

0.30

0.32

mg/l

0.75

619

3803

Volume depletion

360

1127

3.38

92.96

2.2

1.6

0.44

0.30

mg/l

3.38

206

495

ILD differential diagnosis

2758

8943

1.57

92.55

1.8

1.7

0.31

mg/l

0.10

1346

4293

Migraine

1884

8860

1.70

92.01

1.7

0.26

0.30

mg/l

2.45

708

4079

Dental caries, including avohilmo

2157

6756

1.66

91.38

1.7

1.6

0.32

mg/l

0.18

1024

3246

Pneumonia, organism unspecified

3248

15170

1.49

91.32

2.0

1.7

0.33

0.30

mg/l

2.04

1643

7270

Other and unspecified injuries of head

359

1145

3.39

90.91

2.5

1.6

0.46

0.28

mg/l

5.75

235

486

Autism spe, excluding more controls

155

259

6.74

90.74

1.6

1.4

0.15

0.25

mg/l

1.87

121

Acute upper respiratory infections of multiple and unspecified sites

2794

13515

1.54

90.62

1.9

1.7

0.28

0.30

mg/l

1.52

1277

6433

Heart failure,strict

1484

5845

1.81

90.39

1.7

1.6

0.34

0.32

mg/l

0.41

720

2881

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1564

7074

1.77

90.35

1.8

1.7

0.32

mg/l

0.14

716

3507

Persistent delusional disorders

362

1168

3.36

90.09

2.0

1.8

0.23

0.34

mg/l

3.53

150

595

Gout, unspecified

698

3107

2.34

89.97

1.7

0.37

0.32

mg/l

1.68

405

1475

Implicit viral Sepsis

724

3271

2.30

89.77

2.1

1.6

0.31

0.28

mg/l

0.59

345

1495

Bulimia nervosa (incl. atypical)

242

606

4.56

89.60

1.6

1.5

0.25

0.20

mg/l

0.58

234

Viral Sepsis

724

3274

2.30

89.56

2.1

1.6

0.31

0.28

mg/l

0.59

345

1495

Used for control exclusion in common control thyroid runs

3830

13487

1.46

88.97

1.7

1.8

0.28

0.30

mg/l

1.31

1731

6714

Bacterial infection, other or unspecified, including avohilmo

1821

9038

1.69

88.53

1.9

1.7

0.31

0.30

mg/l

0.31

840

4304

Assault by unspecified means

213

500

5.32

88.25

2.5

1.8

0.38

0.29

mg/l

1.20

130

248

Insulin medication

1978

10170

1.65

88.19

1.9

1.8

0.31

mg/l

0.03

898

5086

Other maltreatment syndromes

265

728

4.32

87.77

2.8

1.7

0.36

0.34

mg/l

0.22

184

368

Open wound of wrist and hand

1870

11159

1.67

87.52

2.3

1.7

0.32

0.30

mg/l

0.79

1040

5414

Injuries to the shoulder and upper arm

3004

15752

1.50

87.14

2.0

1.7

0.34

0.30

mg/l

4.42

1695

7445

Open wound of forearm

500

1958

2.75

87.05

2.2

1.7

0.34

0.30

mg/l

0.93

285

929

COPD (mode)

920

3527

2.09

86.99

1.9

1.6

0.36

0.33

mg/l

0.94

508

1687

Fall on and from stairs and steps

989

5096

2.02

86.73

2.2

1.7

0.36

0.31

mg/l

1.80

581

2355

Other specific joint derangements/joint disorders

2827

11759

1.53

86.64

1.7

1.8

0.29

mg/l

0.06

1333

5554

Cardiac arrhythmias

2134

8579

1.63

86.59

1.8

0.35

0.29

mg/l

4.20

1041

4165

Diseases of the skin and subcutaneous tissue

3450

11919

1.48

86.17

1.8

1.7

0.31

0.30

mg/l

0.67

1679

5757

Epilepsy

1086

5754

1.94

86.17

2.0

1.8

0.32

mg/l

0.10

561

2812

Diseases of arteries, arterioles and capillaries (FINNGEN)

805

2579

2.23

86.14

1.8

1.7

0.35

0.29

mg/l

2.10

439

1301

Mental and behavioural disorders due to tobacco

425

1548

2.96

85.36

2.1

1.7

0.33

mg/l

0.01

232

757

ILD medications

4024

15439

1.43

85.21

1.8

0.31

0.30

mg/l

0.69

1904

7412

Benign neoplasm: Colon

1547

8572

1.73

84.73

1.9

1.6

0.33

0.32

mg/l

0.23

760

4115

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

287

831

3.73

84.65

2.7

1.5

0.25

0.31

mg/l

1.11

107

382

Sleep disorders, other/unspecified

256

696

4.18

84.63

2.1

1.6

0.26

0.28

mg/l

0.17

107

318

Other problems related to primary support group, including family circumstances

560

2274

2.55

84.41

2.1

1.7

0.24

0.28

mg/l

1.18

278

992

Autoimmune diseases related-to ILD

2982

17087

1.48

83.41

1.7

1.8

0.31

0.30

mg/l

0.15

1401

8231

Spondylopathies

2459

9467

1.56

83.18

1.8

1.7

0.33

0.32

mg/l

0.15

1268

4636

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2017

11101

1.61

83.06

1.8

1.7

0.31

0.32

mg/l

0.50

933

5362

Disorders of psychological development

705

3031

2.30

82.94

1.9

1.7

0.22

0.24

mg/l

0.29

283

1363

Diseases of pulp and periapical tissues and dental caries

1872

5807

1.68

82.86

1.7

1.6

0.32

0.31

mg/l

0.27

890

2730

Nerve, nerve root and plexus disorders

3582

15156

1.44

82.11

1.8

1.7

0.32

0.31

mg/l

0.96

1754

7288

Benign neoplasm of colon, rectum, anus and anal canal

1825

9545

1.65

82.01

1.9

1.7

0.33

mg/l

0.26

884

4625

Infections with a predominantly sexual mode of transmission, including avohilmo

1743

9832

1.67

81.74

1.8

0.27

0.28

mg/l

0.30

858

4446

Fibromyalgia

411

1507

2.90

80.88

1.5

1.6

0.25

0.29

mg/l

0.60

160

645

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1109

6067

1.89

80.86

1.7

1.8

0.25

0.33

mg/l

6.62

451

3142

Glucagon-like peptide-1 (GLP-1) analogues

1109

6067

1.89

80.86

1.7

1.8

0.25

0.33

mg/l

6.62

451

3142

Dissocial personality disorder

170

359

6.12

80.68

3.1

1.8

0.22

0.33

mg/l

2.52

202

Asthma (diagnoses ohter than nonallergic)

3010

16802

1.47

80.64

1.7

0.30

mg/l

0.11

1403

7917

Insulin, intermediate and long-acting

1829

11067

1.63

79.77

1.9

1.8

0.32

0.31

mg/l

0.09

835

5553

Bacterial infection, other or unspecified

1614

8237

1.69

79.33

1.9

1.6

0.32

0.31

mg/l

0.30

745

3904

severe traumatic brain injury, does not include concussion

737

3533

2.16

78.70

2.6

1.7

0.41

0.32

mg/l

3.76

457

1665

ILD medications: prednisolone, methylprednisolone, prednisone

3774

14991

1.42

78.69

1.8

0.31

0.30

mg/l

0.70

1820

7221

Acetic acid derivatives and related substances

931

2378

2.08

78.63

1.7

1.6

0.28

mg/l

0.16

410

989

Bronchitis

3735

16025

1.42

78.52

1.8

1.7

0.29

0.30

mg/l

0.78

1722

7606

Diseases of oral cavity, salivary glands and jaws

1638

5005

1.72

78.18

1.7

1.6

0.32

mg/l

0.22

768

2421

Abnormalities of heart beat

1177

6401

1.83

77.95

1.7

1.6

0.35

0.29

mg/l

2.63

476

2950

Diseases of the musculoskeletal system and connective tissue

2074

6564

1.62

77.80

1.8

1.7

0.30

0.28

mg/l

0.85

967

3065

COPD/asthma related infections

3394

11911

1.45

77.34

1.8

1.7

0.31

0.29

mg/l

0.92

1571

5562

COPD/asthma/ILD related infections

3394

11911

1.45

77.34

1.8

1.7

0.31

0.29

mg/l

0.92

1571

5562

Other intervertebral disc disorders

2693

10837

1.51

77.17

1.8

1.7

0.33

0.31

mg/l

0.56

1355

5247

Periapical abscess

1730

10826

1.64

77.13

2.0

1.8

0.34

0.32

mg/l

0.92

900

5394

Smoking dependency

425

1632

2.80

77.13

2.1

1.7

0.33

mg/l

0.08

232

803

Autoimmune diseases excluding thyroid diseases

3665

14170

1.42

76.86

1.7

1.8

0.31

0.30

mg/l

0.09

1767

6975

Diaphragmatic hernia

1053

5746

1.88

76.83

1.9

1.6

0.40

0.31

mg/l

3.60

526

2655

Myalgia

883

4590

1.99

75.33

1.7

0.27

0.30

mg/l

0.78

348

2100

Other diseases of hard tissues of teeth

1616

5002

1.70

75.22

1.7

1.6

0.31

0.32

mg/l

0.35

758

2421

Caries of enamel

3442

16060

1.43

75.16

1.8

0.27

0.31

mg/l

4.10

1581

7896

Blood alcohol or alcohol intoxication level

205

527

4.65

74.61

3.2

1.7

0.42

0.31

mg/l

1.61

148

269

1630

10046

1.65

74.46

1.8

0.28

0.30

mg/l

0.40

756

4720

Assault by sharp object

179

421

5.36

74.28

2.7

1.8

0.44

0.31

mg/l

2.14

121

223

Fracture of shoulder and upper arm

1227

7080

1.78

74.00

2.3

1.7

0.36

0.29

mg/l

4.64

739

3270

Acute upper respiratory infections

3427

14634

1.42

73.66

1.8

1.7

0.29

0.30

mg/l

0.47

1571

6904

Other extrapyramidal and movement disorders in other diseases

821

4202

2.02

73.33

1.6

0.29

0.32

mg/l

0.82

346

1902

Autoimmune diseases excluding thyroid diseases, strict definition

3571

13912

1.42

73.27

1.7

1.8

0.31

0.30

mg/l

0.18

1735

6878

COPD

1236

5764

1.78

73.18

1.9

1.7

0.35

0.32

mg/l

1.11

674

2725

Primary biliary cholangitis (PBC)

135

246

6.32

73.01

1.5

1.6

0.27

0.38

mg/l

0.74

113

Spondylosis

1622

7822

1.65

72.80

1.8

1.7

0.33

mg/l

0.02

829

3858

Mycoses, including avohilmo

3236

17561

1.43

72.56

1.7

1.8

0.28

0.30

mg/l

1.40

1436

8494

Dizziness and giddiness

2272

11780

1.52

72.42

1.7

0.33

0.31

mg/l

1.01

973

5590

Asthma, hospital admissions 3, pneumonia

1118

6302

1.81

72.31

1.9

1.7

0.30

mg/l

0.03

552

2874

Asthma-related pneumonia or sepsis

1118

6302

1.81

72.31

1.9

1.7

0.30

mg/l

0.03

552

2874

Asthma-related pneumonia

1115

6287

1.81

72.05

1.9

1.7

0.30

mg/l

0.04

552

2869

Hepatocellular carcinoma

144

284

5.83

71.49

3.1

1.6

0.19

0.36

mg/l

3.20

133

Cellulitis

866

4573

1.97

70.89

2.1

1.8

0.31

0.32

mg/l

0.37

453

2284

Other diseases of pancreas

343

1229

2.98

70.68

2.1

1.6

0.44

0.32

mg/l

2.20

175

603

Irritable bowel syndrome

959

5228

1.89

70.54

1.7

0.25

0.30

mg/l

1.35

347

2339

Hypotension

491

2081

2.44

70.53

1.9

1.5

0.41

0.31

mg/l

2.63

228

900

Dyspnoea

2885

14595

1.45

70.35

1.8

1.7

0.32

0.31

mg/l

0.28

1335

7027

Other chronic obstructive pulmonary disease

1172

5490

1.79

70.28

1.9

1.6

0.35

0.32

mg/l

1.29

634

2581

Diverticular disease of intestine

2060

8356

1.56

70.23

1.8

1.7

0.32

0.33

mg/l

0.36

1035

4189

Statin medication

2398

9069

1.52

69.87

1.8

1.9

0.31

mg/l

0.02

1184

4463

Heart failure, strict

1543

6567

1.66

69.86

1.6

1.7

0.34

0.32

mg/l

0.36

741

3189

Injuries to the elbow and forearm

2474

14553

1.48

69.64

1.9

1.7

0.33

0.29

mg/l

2.22

1303

6733

Coxibs

919

2486

1.99

69.43

1.7

1.6

0.28

mg/l

0.14

437

1029

Unspecified privation

461

1936

2.53

68.90

2.1

1.7

0.35

0.31

mg/l

0.87

241

911

Insulin, combination of fast acting with intermediate-acting or long-acting

1978

11816

1.55

68.73

1.9

1.8

0.31

mg/l

0.00

898

5917

Previous suicide attempt

130

251

6.94

68.72

2.7

1.5

0.26

0.25

mg/l

0.11

106

441

1820

2.58

68.60

1.9

1.6

0.25

mg/l

0.00

218

722

Cholangitis (primary sclerosing, PSC)

269

855

3.38

68.51

1.8

1.7

0.34

0.30

mg/l

0.35

414

All-cause Heart Failure

1507

6416

1.67

68.37

1.6

1.7

0.34

0.32

mg/l

0.45

726

3103

Other joint disorders

3226

11982

1.43

67.97

1.8

0.30

0.29

mg/l

0.36

1561

5661

Abnormalities of gait and mobility

420

1694

2.60

67.95

1.7

1.6

0.33

0.32

mg/l

0.11

208

757

Complications of medical and surgical care

2295

14034

1.49

67.76

1.8

1.7

0.33

0.31

mg/l

1.33

1073

6613

Fracture of foot, except ankle

997

5585

1.85

67.64

2.1

1.7

0.36

0.30

mg/l

2.43

547

2636

Polyarthropathies

2246

9676

1.52

67.53

1.8

0.33

0.30

mg/l

1.26

1149

4650

Other functional intestinal disorders

1378

7605

1.68

67.48

1.7

1.6

0.28

0.29

mg/l

0.34

570

3478

Degeneration of the brain due to alcohol

156

351

5.23

66.99

2.7

1.8

0.56

0.39

mg/l

2.10

106

182

Complications of surgical and medical care, not elsewhere classified

3248

15617

1.41

66.71

1.8

1.7

0.33

0.30

mg/l

2.02

1561

7463

Personal history of risk-factors, not elsewhere classified

140

295

5.94

66.11

2.7

1.6

0.27

0.25

mg/l

0.12

125

Inflammatory bowel disease treatment related agents

3916

16075

1.37

66.03

1.8

0.30

mg/l

0.03

1869

7728

Primary Sclerosing Cholangitis, IBD and UDCA required

168

406

4.87

66.01

1.8

1.7

0.17

0.29

mg/l

2.51

219

Conduct disorder

178

450

4.65

65.92

2.0

1.8

0.28

0.27

mg/l

0.12

223

Degeneration of nervous system due to alcohol

156

356

5.16

65.84

2.7

1.8

0.56

0.40

mg/l

1.95

106

187

Event of undetermined intent

371

1449

2.79

65.74

2.4

1.8

0.32

0.31

mg/l

0.22

223

728

Early onset COPD

754

3902

2.01

65.50

2.1

1.7

0.38

0.33

mg/l

1.25

434

1949

Other CVD

553

2548

2.24

65.15

2.0

1.5

0.39

0.31

mg/l

2.22

256

1110

Noninfective enteritis and colitis

1642

10544

1.59

65.00

1.8

0.28

0.30

mg/l

1.12

743

5062

Covid-19 confirmed case

1180

6984

1.73

64.90

1.9

1.7

0.27

0.30

mg/l

1.11

516

3236

Urinary track infection

1743

5517

1.61

64.90

1.6

1.5

0.28

0.27

mg/l

0.07

722

2161

Medical abortion

1769

6101

1.60

64.84

1.8

1.5

0.29

0.26

mg/l

1.16

852

2182

Cystitis

2560

10535

1.47

64.61

1.6

1.7

0.28

0.30

mg/l

1.01

1081

4774

Any operation in hilmo

191

210

4.87

64.40

1.9

1.5

0.32

mg/l

0.03

Disturbances of skin sensation

1041

5987

1.80

64.39

1.7

0.30

0.31

mg/l

0.36

457

2813

STROKE

1673

7172

1.60

64.34

1.8

0.35

0.32

mg/l

1.07

836

3593

Lumbar disc prolapse

2076

10306

1.52

64.28

1.9

1.7

0.33

0.32

mg/l

0.49

1045

5035

Haemorrhage from respiratory passages

1007

5032

1.81

64.23

1.9

1.7

0.36

0.30

mg/l

2.09

514

2429

Dermatitis and eczema

3792

16649

1.37

63.87

1.8

0.32

0.30

mg/l

1.09

1793

7998

Extrapyramidal and movement disorders

1115

6540

1.75

63.62

1.6

0.28

0.31

mg/l

1.25

461

3016

Arthropathies

3288

11997

1.41

63.59

1.8

0.31

0.29

mg/l

1.19

1584

5668

Nonalcoholic steatohepatitis

105

178

7.96

63.45

2.3

1.5

0.38

0.30

mg/l

0.33

Disorders of mineral metabolism

329

1222

2.85

63.14

2.2

1.7

0.42

0.31

mg/l

1.96

174

561

Complications of procedures, not elsewhere classified

2595

14717

1.44

62.97

1.8

1.7

0.34

0.31

mg/l

1.82

1245

7011

Fracture of lumbar spine and pelvis

649

3226

2.07

62.26

2.1

1.6

0.35

0.31

mg/l

0.94

353

1453

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1169

7010

1.72

62.03

2.4

1.7

0.35

0.30

mg/l

1.93

657

3319

Alcoholic gastritis

117

221

6.42

61.81

3.0

1.7

0.45

0.33

mg/l

1.23

120

Other sleep disorders

455

1991

2.40

61.64

1.8

0.26

0.32

mg/l

1.28

171

979

Necrosis of pulp, including avohilmo

2166

14745

1.48

61.44

2.0

1.8

0.30

0.31

mg/l

0.40

1050

7269

Fracture at wrist and hand level

1349

8385

1.65

61.26

2.2

1.8

0.34

0.30

mg/l

2.31

820

4064

Chronic kidney disease

832

4347

1.89

61.14

1.8

1.6

0.27

0.31

mg/l

0.91

364

2059

Anankastic personality disorder

227

709

3.55

60.45

1.6

1.7

0.23

0.31

mg/l

1.07

336

Injuries to the neck

940

5363

1.82

60.11

2.1

1.8

0.32

0.30

mg/l

0.55

471

2554

Unspecified jaundice

201

577

3.73

60.07

2.5

1.6

0.46

0.30

mg/l

2.11

110

277

356

1418

2.66

59.62

2.4

1.7

0.55

0.32

mg/l

8.66

276

715

3611

13554

1.37

59.52

1.8

1.7

0.30

mg/l

0.16

1654

6370

Habit and impulse disorders

155

386

4.90

59.34

2.3

1.7

0.29

0.28

mg/l

0.08

199

Personal history of certain other diseases

160

405

4.66

59.32

2.8

1.5

0.22

0.24

mg/l

0.20

155

Unspecified kidney failure

326

1240

2.75

59.29

2.0

1.5

0.42

0.30

mg/l

2.04

167

557

Other degenerative diseases of the nervous system

715

2673

1.99

59.24

1.8

1.6

0.38

0.28

mg/l

3.88

367

1163

COPD related to multimorbidity

1004

4891

1.77

59.17

1.9

1.6

0.34

0.31

mg/l

1.01

540

2279

Hypothyroidism, strict autoimmune

2274

10323

1.47

58.68

1.7

0.27

0.31

mg/l

1.56

916

4853

Other heart diseases, wide

3188

14129

1.39

58.63

1.8

0.35

0.30

mg/l

4.09

1574

6862

Non-ischemic cardiomyopathy

830

3585

1.88

58.58

1.7

1.6

0.34

0.32

mg/l

0.38

418

1694

Idiopathic gout

336

1314

2.70

58.23

1.9

1.6

0.30

0.32

mg/l

0.15

208

630

Candidiasis, including avohilmo

1026

6057

1.74

57.58

1.8

1.6

0.30

mg/l

0.02

412

2658

Vocal cord dysfunction

317

1043

2.75

57.31

1.7

1.3

0.31

0.27

mg/l

0.69

153

444

Fall on same level involving ice and snow

1888

12841

1.50

56.97

2.0

1.7

0.35

0.30

mg/l

3.33

968

5990

COPD, hospital admissions

1161

5924

1.68

56.96

1.9

1.6

0.35

0.32

mg/l

1.28

630

2780

Malignant neoplasm of liver and intrahepatic bile ducts

157

397

4.36

56.88

3.0

1.5

0.17

0.34

mg/l

4.67

181

COPD, early/later onset

1172

5978

1.68

56.73

1.9

1.6

0.35

0.32

mg/l

1.23

634

2808

Oral corticosteroids

3486

15248

1.36

56.40

1.8

0.31

mg/l

0.36

1682

7367

Hyperkinetic disorders (excl. ADHD)

155

393

4.55

55.84

2.3

1.8

0.21

0.27

mg/l

0.64

198

Focal brain injury

246

841

3.09

54.98

2.7

1.7

0.40

0.31

mg/l

1.25

149

404

Behavioural disorders

178

513

4.06

54.94

2.2

1.8

0.28

0.26

mg/l

0.17

248

Abnormal results of function studies

375

1593

2.49

54.74

1.7

0.25

0.31

mg/l

1.45

140

759

Other disorders of urethra and urinary system

2032

9726

1.47

54.47

1.7

1.6

0.29

0.30

mg/l

0.18

848

4352

Symptoms and signs involving the skin and subcutaneous tissue

2271

15218

1.43

54.04

1.7

0.31

mg/l

0.04

1026

7202

Other acute viral hepatitis

119

260

5.70

53.90

2.9

1.7

0.30

0.34

mg/l

0.39

120

Other mental disorders due to brain damage and dysfunction and to physical disease

358

1493

2.50

53.76

2.0

1.6

0.30

0.31

mg/l

0.09

176

676

Toxic effect of ethanol

248

877

3.14

53.73

2.5

1.7

0.33

0.32

mg/l

0.18

166

428

Acute tubulo-interstitial nephritis

1787

10230

1.50

53.21

1.8

1.6

0.30

0.29

mg/l

0.46

803

4512

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1793

12003

1.49

52.88

1.7

0.34

0.31

mg/l

1.08

833

5617

Restless leg syndrome

502

2432

2.15

52.73

1.5

1.7

0.22

0.31

mg/l

3.47

208

1098

Other diseases of intestine

490

2348

2.16

52.65

1.9

1.6

0.35

0.32

mg/l

0.63

256

1116

Invasive ventilation

297

1153

2.74

52.60

2.2

1.7

0.38

0.34

mg/l

0.65

182

561

Inflammatory diseases of female pelvic organs

1784

8245

1.50

52.56

1.6

0.26

0.28

mg/l

0.72

704

3254

Abnormal involuntary movements

485

2324

2.18

52.47

1.8

1.7

0.33

0.30

mg/l

0.41

201

1085

Dental operations

1697

5762

1.54

52.46

1.8

1.6

0.32

0.33

mg/l

0.21

831

2793

Migraine with aura

884

5141

1.77

52.35

1.8

1.7

0.24

0.29

mg/l

1.88

327

2289

All chronic kidney diseases

1576

8324

1.54

52.30

1.8

1.7

0.33

0.30

mg/l

0.98

708

3991

Hyperlipidaemia, other/unspecified

977

5215

1.72

52.20

1.7

0.33

0.31

mg/l

0.40

471

2517

ILD medications: immunosuppressive drugs

2164

13873

1.44

52.13

1.9

1.8

0.29

0.31

mg/l

0.81

965

6760

Toxic effect of other and unspecified substances

122

281

5.35

51.75

2.8

1.7

0.37

0.29

mg/l

0.79

141

First line medication for Crohn's disease

3752

15382

1.33

51.69

1.8

0.30

mg/l

0.19

1774

7390

Symptoms and signs involving the urinary system

2285

12272

1.42

51.57

1.8

0.30

0.32

mg/l

0.48

998

6040

Iron deficiency anaemia secondary to blood loss (chronic)

465

2203

2.18

51.36

2.1

1.6

0.38

0.31

mg/l

1.67

243

976

Symptoms and signs involving emotional state

182

551

3.67

51.10

2.1

1.7

0.24

0.29

mg/l

0.59

258

Open wound of lower leg

554

2814

2.05

51.02

2.1

1.7

0.34

0.30

mg/l

1.03

308

1286

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1659

11230

1.50

50.68

1.7

0.34

0.31

mg/l

1.25

756

5232

Other diseases of urinary system

3080

12861

1.36

50.45

1.7

0.28

0.31

mg/l

1.72

1360

6173

Diseases of the respiratory system

2024

6996

1.47

50.39

1.7

0.29

0.30

mg/l

0.19

951

3240

Other and unspecified myopathies

322

1327

2.56

50.09

2.1

1.7

0.35

0.32

mg/l

0.41

164

639

Osteopathies and chondropathies

1677

10423

1.50

50.08

1.9

1.7

0.34

0.31

mg/l

0.98

825

4895

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

196

624

3.35

49.77

2.8

1.4

0.20

0.33

mg/l

3.62

276

Infections with a predominantly sexual mode of transmission

1188

7546

1.61

49.69

1.8

0.27

0.29

mg/l

0.62

565

3435

Hard cardiovascular diseases

2499

10678

1.40

49.49

1.8

0.35

0.33

mg/l

1.04

1281

5371

Tobacco use

278

1084

2.78

49.44

2.4

1.7

0.34

0.31

mg/l

0.27

161

535

Weight loss

363

1596

2.39

48.75

1.8

1.6

0.33

0.30

mg/l

0.50

155

707

Evidence of alcohol involvement determined by blood alcohol level

128

320

4.83

48.72

3.3

1.6

0.47

0.32

mg/l

1.78

152

Diseases of the myoneural junction and muscle

422

1979

2.23

48.32

2.0

1.7

0.34

0.32

mg/l

0.35

209

933

Sequelae of injuries, of poisoning and of other consequences of external causes

882

5259

1.73

48.18

2.1

1.8

0.34

0.32

mg/l

0.39

506

2623

Implicit fungal Sepsis, including avohilmo

257

968

2.80

48.10

2.0

1.6

0.33

0.28

mg/l

0.61

113

422

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

269

690

2.82

47.98

1.8

1.5

0.35

0.28

mg/l

0.87

134

311

Excessive attrition of teeth

2128

15123

1.42

47.97

1.8

0.27

0.31

mg/l

2.91

975

7223

Superficial injury of thorax

556

2891

2.00

47.91

2.3

1.7

0.36

0.30

mg/l

1.28

317

1387

Elevated blood glucose level

330

1410

2.47

47.54

2.1

1.7

0.37

0.31

mg/l

0.69

158

677

Explicit bacterial Sepsis, including avohilmo

369

1653

2.33

47.17

2.1

1.6

0.37

0.28

mg/l

2.15

188

769

Autoimmune hepatitis

137

7.23

47.04

1.6

1.5

0.13

0.37

mg/l

2.99

Specific development disorders of scholastic skills

277

1086

2.74

46.90

2.2

1.7

0.24

0.23

mg/l

0.03

110

486

Oxicams

615

1810

1.97

46.84

1.8

1.6

0.31

mg/l

0.07

298

772

Codes for special purposes

1704

11707

1.47

46.84

1.8

1.7

0.27

0.30

mg/l

1.26

741

5456

Abnormal weight loss

335

1449

2.43

46.80

1.8

1.6

0.34

0.31

mg/l

0.46

140

650

Assault by blunt object

134

358

4.54

46.75

2.8

1.7

0.35

0.32

mg/l

0.26

177

Provisional assignment of new diseases of uncertain etiology

1702

11701

1.47

46.65

1.8

1.7

0.27

0.30

mg/l

1.22

740

5452

Traumatic subarachnoid haemorrhage

142

383

3.96

46.57

2.4

1.6

0.40

0.30

mg/l

0.94

173

Other symptoms and signs involving the nervous and musculoskeletal systems

1286

8439

1.55

46.50

1.8

1.7

0.32

0.31

mg/l

0.45

590

3958

Acute bronchitis

1243

7935

1.57

46.40

1.8

1.7

0.30

mg/l

0.18

578

3722

Irregular menses

1496

7547

1.52

46.29

1.7

1.6

0.26

0.27

mg/l

0.61

588

3052

Superficial injury of lower leg

891

5379

1.70

46.10

1.9

1.7

0.32

0.29

mg/l

0.82

427

2391

Other arthrosis

1566

7091

1.50

45.97

1.8

0.33

0.32

mg/l

0.13

800

3539

Other acute lower respiratory infections

1734

11514

1.46

45.81

1.8

0.30

mg/l

0.00

815

5469

Toxic liver disease

100

213

5.44

45.74

2.0

1.6

0.32

0.34

mg/l

0.11

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1490

9999

1.50

45.65

1.9

1.8

0.28

0.29

mg/l

0.46

705

4644

Superficial injury of wrist and hand

805

4756

1.75

45.49

2.0

1.7

0.28

0.29

mg/l

0.07

404

2154

Dermatitis

1903

13235

1.43

45.10

1.8

1.7

0.32

0.30

mg/l

0.59

917

6212

Transplanted organ and tissue status

390

1829

2.25

45.04

3.0

1.7

0.23

0.33

mg/l

2.43

145

917

Dysphagia

671

3763

1.82

44.95

1.6

0.35

0.30

mg/l

1.17

280

1755

Other diseases of lip and oral mucosa

1307

8674

1.54

44.95

1.9

1.7

0.32

0.31

mg/l

0.24

629

4070

Arthrosis

2164

8504

1.41

44.39

1.8

0.34

0.32

mg/l

0.87

1076

4195

Other noninfective gastroenteritis and colitis

792

4686

1.73

44.09

1.9

1.7

0.29

0.30

mg/l

0.24

346

2145

Speech and linguistic disorders

448

2143

2.12

43.87

2.0

1.8

0.23

mg/l

0.01

186

972

Hyperkalaemia

192

649

3.11

43.83

2.1

1.6

0.35

0.34

mg/l

0.15

282

Disorders of thyroid, IBD co-morbidities

494

1690

2.05

43.63

1.5

1.6

0.25

0.27

mg/l

0.28

184

717

Fibrosis of liver

129

7.45

43.25

2.1

1.6

0.37

0.38

mg/l

0.04

Use of biperiden

237

911

2.80

43.24

2.2

1.7

0.21

0.34

mg/l

3.87

475

Propionic acid derivatives

872

2585

1.73

42.83

1.7

1.6

0.30

0.27

mg/l

0.74

415

1071

Finngen Rheumatological endpoints

3219

14030

1.32

42.56

1.8

0.32

0.30

mg/l

1.32

1556

6709

Other diseases of biliary tract

273

1122

2.54

42.55

2.1

1.6

0.38

0.30

mg/l

0.76

523

Cervicalgia

618

3453

1.84

42.14

1.8

1.6

0.33

0.31

mg/l

0.35

315

1608

Other general symptoms and signs

220

813

2.84

42.08

2.0

1.6

0.26

mg/l

0.04

357

Explicit bacterial Sepsis

350

1609

2.26

42.04

2.1

1.6

0.37

0.28

mg/l

2.18

177

749

Assault by other specified means

102

242

5.27

41.99

3.1

1.8

0.38

0.33

mg/l

0.50

119

Cerebrovascular diseases

1931

9583

1.42

41.84

1.7

0.35

0.32

mg/l

1.19

958

4685

Hernia of abdominal wall

1370

9317

1.50

41.79

2.0

1.8

0.35

0.32

mg/l

0.94

713

4626

Cholelithiasis, broad definition with cholecystitis

2358

11601

1.37

41.51

1.7

1.6

0.30

0.31

mg/l

0.07

866

5594

Undetermined asthma, excluding more controls

410

2021

2.09

40.81

1.7

1.6

0.30

0.31

mg/l

0.12

171

888

COPD, hospital admission 2, with asthma infections

781

4023

1.70

40.51

2.0

1.6

0.37

0.31

mg/l

2.20

416

1870

Anorexia (incl.atypical)

260

1074

2.57

40.51

1.6

1.5

0.23

0.25

mg/l

0.19

443

Lesion of ulnar nerve

492

2604

1.96

40.34

2.1

1.8

0.38

0.32

mg/l

1.27

280

1326

Superficial injury of abdomen, lower back and pelvis

580

3233

1.86

40.29

2.1

1.7

0.31

0.29

mg/l

0.31

303

1476

Benign neoplasm: Colon, unspecified

659

3802

1.78

40.24

1.8

1.6

0.32

mg/l

0.08

331

1767

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2880

13906

1.32

40.23

1.9

1.7

0.34

0.32

mg/l

1.06

1299

6902

Heart failure and bmi 25plus

918

3786

1.65

40.17

1.7

0.35

0.30

mg/l

1.81

442

1877

Fenamates

410

1345

2.13

40.07

1.4

1.6

0.31

mg/l

0.01

135

531

Other and unspecified dermatitis

1568

11018

1.45

40.05

1.7

0.31

0.30

mg/l

0.15

724

5136

Paracetamol or NSAID medication

563

1494

1.94

40.02

1.8

1.7

0.30

0.26

mg/l

0.89

278

617

Spinal stenosis

1221

5962

1.53

40.00

1.6

1.7

0.35

0.33

mg/l

0.49

613

2897

Migraine without aura

719

4262

1.73

39.99

1.7

0.25

0.29

mg/l

1.10

244

1860

Anti-inflammatory and antirheumatic products, non-steroids

859

2585

1.70

39.98

1.7

1.6

0.30

0.27

mg/l

0.78

408

1071

Inflammatory bowel disease

1116

7357

1.55

39.96

1.7

1.8

0.26

0.31

mg/l

2.44

518

3606

Dialysis, with operation codes

431

2194

2.05

39.72

2.5

1.7

0.29

0.32

mg/l

0.41

200

1097

Visual disturbances and blindness

1526

10683

1.45

39.59

1.8

1.7

0.28

0.30

mg/l

0.59

652

4960

Genitourinary diseases

2153

7876

1.39

39.59

1.9

0.30

0.32

mg/l

0.76

1073

4271

Functional dyspepsia

770

4654

1.69

39.56

1.7

1.6

0.31

0.30

mg/l

0.22

315

2120

Cholelithiasis

2238

11307

1.37

39.25

1.7

1.6

0.29

0.31

mg/l

0.38

814

5435

Asthma, hospital admissions , main diagnosis only

2594

17197

1.33

38.78

1.7

0.29

0.30

mg/l

0.50

1226

8118

Undetermined asthma

410

2060

2.05

38.74

1.7

1.6

0.30

0.31

mg/l

0.14

171

909

Hypothyroidism, other/unspecified

2637

13167

1.33

38.71

1.7

0.27

0.31

mg/l

2.07

1051

6209

Paranoid personality disorder

116

316

4.17

38.57

1.9

1.6

0.18

0.32

mg/l

2.61

144

L04AD Calcineurin inhibitors

429

2210

2.04

38.52

2.8

1.7

0.23

0.33

mg/l

3.82

166

1101

Shoulder lesions

2169

9576

1.37

38.45

1.8

1.7

0.33

0.32

mg/l

0.26

1088

4743

Injuries to the hip and thigh

1351

8316

1.48

38.43

1.9

1.7

0.33

0.31

mg/l

0.76

694

3871

Streptococcal septicaemia, including avohilmo

301

1352

2.32

38.42

2.2

1.6

0.38

0.31

mg/l

1.07

149

625

Pain and other conditions associated with female genital organs and menstrual cycle

735

3676

1.72

38.40

1.5

1.6

0.22

0.27

mg/l

1.25

239

1499

Budesonide

519

2840

1.89

38.35

1.5

1.8

0.22

0.30

mg/l

3.00

210

1317

Vitamin deficiency, wide

191

699

2.91

38.10

2.2

1.7

0.46

0.32

mg/l

1.68

326

Vitamin deficiency

191

699

2.91

38.10

2.2

1.7

0.46

0.32

mg/l

1.68

326

Ulcer of lower limb, not elsewhere classified

417

2125

2.03

38.00

1.9

1.6

0.33

0.32

mg/l

0.21

199

990

Schizotypal disorder

146

469

3.50

37.67

2.1

1.8

0.23

0.33

mg/l

1.55

247

Acute sinusitis

1782

11741

1.40

37.66

1.9

1.8

0.31

mg/l

0.10

836

5639

Soft tissue disorders related to use, overuse and pressure

787

4853

1.66

37.39

1.9

1.7

0.35

0.32

mg/l

0.53

399

2353

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3114

15344

1.30

37.32

1.9

1.7

0.31

mg/l

0.03

1465

7345

Erosion of teeth , including avohilmo

1007

6600

1.57

37.22

2.0

1.8

0.27

0.30

mg/l

0.95

493

3110

Hypothyreosis and Thyroxine purchase for inclusion criteria

2691

13497

1.32

37.22

1.7

0.28

0.31

mg/l

1.72

1071

6317

Rotator cuff syndrome

1712

8436

1.42

37.19

1.8

1.7

0.32

mg/l

0.04

884

4207

Insulin, fast-acting

1141

7671

1.52

36.94

1.9

1.8

0.32

0.31

mg/l

0.21

532

3788

Burns and corrosions

554

3136

1.84

36.87

2.5

1.8

0.32

0.31

mg/l

0.07

331

1556

Tic and related disorders

116

6.30

36.75

2.2

1.5

0.17

0.26

mg/l

1.03

Diseases of the eye and adnexa

2882

11123

1.31

36.62

1.8

0.30

mg/l

0.09

1366

5534

Duodenal ulcer

286

1280

2.31

36.55

2.4

1.6

0.45

0.29

mg/l

4.41

175

589

Poisoning by medicine, drug-induced

100

258

4.59

36.39

2.4

1.7

0.45

0.32

mg/l

0.88

122

Sequelae of external causes of morbidity and mortality

756

4655

1.66

36.29

2.0

1.7

0.32

0.31

mg/l

0.12

376

2174

Visual disturbances

1423

10019

1.44

36.11

1.8

1.7

0.28

0.30

mg/l

0.67

616

4662

161

547

3.04

36.04

2.4

1.6

0.20

0.26

mg/l

1.05

241

Other diseases of anus and rectum

804

5009

1.63

35.92

1.8

1.6

0.32

0.30

mg/l

0.48

359

2312

Cervical disc disorders

964

6291

1.56

35.84

1.8

1.7

0.34

0.33

mg/l

0.42

517

3079

Alcohol induced polyneuropathy

183

5.35

35.11

2.9

1.8

0.58

0.40

mg/l

1.55

Alzheimer disease, excluding more controls

287

810

2.33

34.97

1.4

1.3

0.32

0.26

mg/l

0.90

138

313

Acidosis

103

275

4.13

34.84

2.3

1.7

0.50

0.33

mg/l

1.73

133

Psoriasis

916

5962

1.57

34.83

1.8

1.7

0.36

0.32

mg/l

1.32

488

2897

Streptococcal septicaemia

287

1319

2.26

34.68

2.2

1.6

0.38

0.31

mg/l

1.16

140

610

Injuries to unspecified part of trunk, limb or body region

370

1879

2.05

34.46

2.2

1.7

0.36

0.31

mg/l

0.96

191

876

Open wound of ankle and foot

402

2104

1.99

34.37

2.0

1.7

0.35

0.30

mg/l

0.87

224

1009

Type of accident

967

6389

1.55

34.30

2.3

1.7

0.35

0.30

mg/l

1.52

520

3015

Cardiomyopathy

491

2731

1.85

34.09

1.7

0.38

0.32

mg/l

1.20

238

1382

Hypothyroidism, strict autoimmune, 3 medication purchases required

2389

12258

1.32

33.93

1.7

0.27

0.30

mg/l

1.98

951

5642

Atopic dermatitis

2102

12618

1.35

33.90

1.6

1.8

0.30

0.29

mg/l

0.13

942

5980

Striking against or struck by other objects

1282

8967

1.46

33.90

2.0

1.8

0.34

0.30

mg/l

1.47

667

4457

Anxious personality disorder

128

406

3.55

33.79

2.2

1.7

0.19

0.27

mg/l

1.47

196

Sequelae of injuries of head

241

1053

2.44

33.52

2.3

1.8

0.42

0.32

mg/l

1.34

160

538

Use of pramipexole

570

3328

1.75

33.50

1.6

0.28

0.31

mg/l

0.79

241

1502

Hypertension, portal

10.92

33.45

2.2

1.5

0.40

mg/l

0.00

Non-invasive ventilation

461

2158

1.87

33.43

1.9

1.4

0.37

0.25

mg/l

3.45

231

977

Thrombocytopenia, unspecified

250

1105

2.37

33.41

2.0

1.6

0.37

0.33

mg/l

0.34

110

516

Oxycodone

925

5165

1.55

33.31

1.9

1.6

0.32

0.31

mg/l

0.07

429

2379

Chronic rhinitis, nasopharyngitis and pharyngitis

1032

6956

1.51

33.10

1.7

0.28

0.31

mg/l

1.51

409

3273

Cholangitis (primary sclerosing, PSC), with reimbursement 202

117

356

3.72

33.05

1.6

1.7

0.17

0.31

mg/l

2.23

176

130

423

3.47

32.97

1.8

1.6

0.21

0.20

mg/l

0.03

176

Superficial injury of ankle and foot

493

2797

1.83

32.55

2.0

1.7

0.28

0.29

mg/l

0.18

252

1284

Senile cataract

1556

6793

1.41

32.50

1.8

1.7

0.37

0.32

mg/l

2.38

776

3394

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

259

1155

2.33

32.43

1.9

1.6

0.19

0.25

mg/l

1.18

111

499

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

816

5272

1.59

32.41

1.8

0.28

mg/l

0.17

403

2378

Insulin, fast-acting or short human

1143

7891

1.48

32.39

1.9

1.8

0.32

0.31

mg/l

0.21

533

3860

Disorders of iron metabolism

100

278

4.07

32.33

2.0

1.7

0.34

0.36

mg/l

0.10

126

Nephropathy related operations

408

2189

1.94

32.31

2.5

1.7

0.28

0.32

mg/l

0.71

187

1093

Ischemic heart diseases

2337

10641

1.32

32.26

1.8

0.34

0.33

mg/l

0.59

1177

5396

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

309

1508

2.13

32.13

2.0

1.6

0.33

0.30

mg/l

0.42

161

691

Disorders of other endocrine glands

1320

9224

1.43

31.94

1.8

1.7

0.27

0.30

mg/l

0.98

541

4284

Migraine with aura and triptan purchases

584

3492

1.72

31.77

1.7

0.24

0.27

mg/l

0.67

210

1518

Contact with sharp glass

218

940

2.51

31.64

2.5

1.7

0.35

0.31

mg/l

0.55

131

467

Disorders of tooth development and eruption

527

2468

1.78

31.58

1.9

1.7

0.30

0.32

mg/l

0.34

260

1185

Psoriasis vulgaris

621

3784

1.69

31.42

1.9

1.8

0.35

0.32

mg/l

0.60

336

1863

Wide developmental disorders

208

878

2.57

31.40

1.6

1.7

0.15

0.23

mg/l

2.60

402

Umbilical hernia

879

5805

1.55

31.34

2.1

1.8

0.32

mg/l

0.01

464

2991

Pneumonitis due to solids and liquids

245

1100

2.31

31.32

2.6

1.7

0.40

0.32

mg/l

0.93

141

518

Diffuse brain injury

142

493

3.05

31.25

2.7

1.7

0.35

0.29

mg/l

0.61

234

Papulosquamous disorders

1153

8035

1.46

31.16

1.8

1.7

0.34

0.32

mg/l

0.89

600

3864

Abnormal findings on diagnostic imaging of other body structures

418

2282

1.89

31.07

1.9

1.6

0.30

0.31

mg/l

0.15

177

1042

Disorder of lipoprotein metabolism, unspecified

324

1623

2.05

31.00

1.6

0.36

0.31

mg/l

0.67

151

746

Radiculopathy

403

2173

1.90

30.94

1.7

1.6

0.35

0.31

mg/l

0.77

177

977

Polycystic ovarian syndrome, consortium definition

1897

8120

1.36

30.87

1.6

0.26

0.27

mg/l

0.47

722

3243

Artrosis, including avohilmo

2534

10773

1.30

30.79

1.8

0.34

0.32

mg/l

0.64

1259

5358

Other disorders of glucose regulation and pancreatic internal secretion

299

1466

2.13

30.78

2.0

1.7

0.37

0.31

mg/l

0.93

162

707

Ulcerative colitis

844

5554

1.56

30.68

1.7

1.8

0.26

0.31

mg/l

2.31

388

2739

Dermatophytosis, including avohilmo

2115

15919

1.32

30.61

1.8

0.28

0.31

mg/l

1.81

977

7806

Crohn disease

490

2827

1.80

30.58

1.7

1.8

0.29

0.32

mg/l

0.45

217

1373

Inflammatory disease of uterus

443

2477

1.84

30.53

1.7

1.5

0.22

0.28

mg/l

1.77

161

972

Injury of other and unspecified intrathoracic organs

244

1112

2.31

30.48

2.6

1.7

0.39

0.33

mg/l

0.97

157

539

Adjustment and management of implanted device

422

2320

1.86

30.41

1.5

1.6

0.28

0.29

mg/l

0.14

192

1039

Purpura and other haemorrhagic conditions

424

2344

1.87

30.37

1.9

1.6

0.34

0.30

mg/l

0.60

198

1078

Collagenous colitis

297

1460

2.12

30.28

1.9

1.6

0.31

mg/l

0.05

133

664

Abnormal findings on diagnostic imaging of lung

1160

7702

1.45

29.87

1.7

1.6

0.32

mg/l

0.04

572

3676

Car occupant injured in other and unspecified transport accidents

690

4372

1.62

29.84

2.3

1.8

0.25

0.30

mg/l

1.64

350

2038

Combinations of oral blood glucose lowering drugs

731

4684

1.59

29.73

1.7

0.30

0.34

mg/l

0.93

339

2401

Folate deficiency anaemia

123

5.66

29.70

2.3

1.5

0.41

0.40

mg/l

0.02

Open wound of abdomen, lower back and pelvis

166

649

2.78

29.70

3.0

1.7

0.28

0.31

mg/l

0.31

107

335

Injury of eye and orbit

522

3088

1.74

29.66

2.2

1.7

0.36

0.28

mg/l

2.19

311

1476

Other and unspecified tonsillitis

1381

8310

1.41

29.54

1.9

0.30

mg/l

0.15

708

4167

Evidence of alcohol involvement determined by level of intoxication

237

4.36

29.52

3.1

1.5

0.34

0.28

mg/l

0.49

105

Disorders of lens

1765

8161

1.36

29.36

1.8

1.7

0.37

0.33

mg/l

2.23

877

4122

Scabies, including avohilmo

604

3727

1.67

29.31

2.1

1.8

0.31

0.29

mg/l

0.57

330

1737

Burns and corrosions of external body surface, specified by site

426

2396

1.85

29.15

2.6

1.8

0.30

0.31

mg/l

0.07

252

1172

Other sexually transmitted chlamydial diseases, including avohilmo

500

2950

1.77

29.13

1.9

1.8

0.24

0.25

mg/l

0.14

251

1283

Coagulation defects, purpura and other haemorrhagic conditions

587

3592

1.68

29.10

1.9

1.6

0.34

0.30

mg/l

0.68

273

1633

Diseases of middle ear and mastoid

1992

12450

1.32

29.08

1.8

0.25

0.30

mg/l

3.45

940

5873

Chronic hepatitis NAS

201

4.50

29.02

2.6

1.5

0.33

0.35

mg/l

0.09

Later onset COPD, excluding more controls

409

1697

1.87

28.91

1.6

1.4

0.29

0.30

mg/l

0.14

198

699

Polyuria

605

3733

1.66

28.89

1.6

0.25

0.31

mg/l

2.21

268

1788

Injuries involving multiple body regions

181

747

2.60

28.76

2.8

1.7

0.38

0.30

mg/l

1.08

113

357

Superficial injuries involving multiple body regions

140

513

2.98

28.44

2.9

1.7

0.34

0.30

mg/l

0.41

239

Social disorders starting during childhood or adolecense, excluding more controls

7.45

28.43

1.4

1.6

0.23

0.24

mg/l

0.04

Disorder of the sleep-wake schedule

108

343

3.51

28.41

1.7

0.21

0.28

mg/l

0.61

167

Diseases of arteries, arterioles and capillaries

1658

9064

1.36

28.36

1.7

0.32

mg/l

0.07

831

4383

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

276

3.92

28.32

2.9

1.6

0.28

0.32

mg/l

0.29

128

Disorders of the thyroid gland

2772

14313

1.27

28.32

1.7

0.26

0.31

mg/l

3.42

1096

6839

Cervicobrachial syndrome

622

3885

1.64

28.25

1.9

1.7

0.31

mg/l

0.04

318

1833

Maternal care for (suspected) damage to fetus from alcohol

9.18

28.23

2.8

1.5

0.31

0.27

mg/l

0.15

Memory loss

232

1066

2.25

28.06

1.6

0.31

0.32

mg/l

0.07

109

452

Pediculosis, acariasis and other infestations, including avohilmo

666

4249

1.61

28.05

2.1

1.8

0.33

0.29

mg/l

0.96

363

1979

Other and unspecified drugs and medicaments

289

1450

2.08

27.98

2.0

1.7

0.32

0.31

mg/l

0.13

148

672

Other diseases of upper respiratory tract

3304

13936

1.25

27.96

1.7

1.8

0.29

0.30

mg/l

1.00

1592

6667

Other specified/unspecified arthritis

772

5083

1.55

27.80

1.9

1.7

0.31

mg/l

0.07

401

2382

Peripheral artery disease

935

5015

1.49

27.72

1.6

0.30

0.32

mg/l

0.40

458

2343

Adverse effects, not elsewhere classified

634

4009

1.62

27.57

1.7

0.35

0.29

mg/l

1.89

270

1752

Portal vein thrombosis

250

3.93

27.48

2.3

1.7

0.38

0.36

mg/l

0.10

121

Hypertensive heart and/or renal disease

555

2446

1.68

27.24

1.6

0.37

0.31

mg/l

1.25

261

1113

Benign neoplasm: Sigmoid colon

485

2876

1.73

27.09

2.0

1.6

0.34

0.33

mg/l

0.16

247

1345

Anogenital herpesviral [herpes simplex] infection, including avohilmo

448

2614

1.78

26.99

1.9

1.7

0.26

0.28

mg/l

0.59

218

1143

Cholecystectomy

1804

11681

1.32

26.96

1.6

1.7

0.27

0.32

mg/l

2.18

609

5582

Cough

1106

7312

1.43

26.89

1.7

0.31

0.29

mg/l

0.73

459

3407

Any dementia, excluding more controls

545

2244

1.69

26.88

1.5

1.3

0.33

0.24

mg/l

2.94

243

811

Colitis, primary sclerosing

100

317

3.63

26.80

1.6

1.7

0.22

0.30

mg/l

0.67

161

Secondary parkinsonism, excluding more controls

152

4.56

26.75

1.7

1.2

0.22

0.29

mg/l

0.43

Dislocation, sprain and strain of joints and ligaments of knee

2000

14025

1.31

26.73

1.8

1.7

0.31

0.29

mg/l

0.51

1024

6606

Superficial injury of forearm

381

2127

1.86

26.68

2.1

1.7

0.32

0.29

mg/l

0.54

195

978

Mental and behavioural disorders due to hallucinogens

128

5.90

26.47

3.0

1.6

0.23

0.31

mg/l

0.54

Oesophagitis

177

746

2.49

26.45

2.3

1.7

0.38

0.30

mg/l

0.97

110

357

Small fibre neuropathy

130

475

2.96

26.44

1.8

1.7

0.38

0.36

mg/l

0.15

230

Personal history of other diseases and conditions

400

2258

1.82

26.43

2.0

1.6

0.26

0.27

mg/l

0.08

180

927

Allergic asthma (mode), excluding more controls

751

4847

1.54

26.42

1.7

0.27

0.28

mg/l

0.40

335

2225

Haemorrhoids and perianal venous thrombosis

853

5748

1.50

26.34

1.8

1.7

0.35

0.31

mg/l

1.40

408

2679

Hernia

2765

14756

1.26

26.31

1.9

1.8

0.35

0.30

mg/l

3.31

1402

7204

Somnolence, stupor and coma

156

623

2.64

26.26

2.5

1.7

0.30

0.33

mg/l

0.23

303

Paroxysmal tachycardia

613

3207

1.62

26.11

1.6

1.7

0.33

0.27

mg/l

1.54

266

1504

Other bacterial intestinal infections, including avohilmo

654

4213

1.58

26.08

2.1

1.7

0.34

0.30

mg/l

1.14

309

1964

Disorders of skin appendages

1633

12335

1.34

26.00

1.8

0.30

0.29

mg/l

0.24

745

5774

Pregnancy with abortive outcome

1602

6217

1.36

25.99

1.7

1.5

0.28

0.26

mg/l

0.76

717

2221

Open wound of thorax

103

338

3.46

25.95

2.9

1.7

0.42

0.31

mg/l

1.32

167

Heartburn

338

1830

1.90

25.89

1.8

1.6

0.41

0.30

mg/l

1.73

146

855

Exclusions for E4_PCOS_BROAD

576

3622

1.63

25.67

1.7

1.8

0.27

0.31

mg/l

1.03

238

1742

IBD patients in KELA-register

816

5545

1.51

25.57

1.6

1.8

0.24

0.31

mg/l

3.01

369

2760

Noninfectious colitis NAS

427

2496

1.76

25.33

1.9

1.7

0.29

0.30

mg/l

0.16

185

1180

Chronic sinusitis

1258

9216

1.38

25.24

1.8

0.30

0.32

mg/l

0.29

565

4410

Allergic asthma (mode)

751

4898

1.52

25.18

1.7

0.27

0.29

mg/l

0.51

335

2254

Hypertensive Heart Disease

497

2261

1.69

25.18

1.6

0.37

0.30

mg/l

1.42

235

1020

Nonischemic cardiomyopathy

295

1543

1.97

25.16

1.8

1.7

0.43

0.32

mg/l

2.01

163

755

Lesion of lateral popliteal nerve

179

779

2.42

25.05

2.2

1.7

0.40

0.34

mg/l

0.74

113

383

5-aminosalicylic acid

730

4870

1.53

25.00

1.6

1.8

0.26

0.31

mg/l

2.20

333

2416

Heart failure and coronary heart disease

945

4585

1.46

24.88

1.6

1.7

0.33

0.32

mg/l

0.07

445

2217

Mental retardation, excluding more controls

104

330

3.18

24.85

1.9

1.4

0.22

0.27

mg/l

0.57

160

Oter anti-inflammatory and antirheumatic agents, non-steroids

454

1438

1.76

24.79

1.7

0.29

0.32

mg/l

0.47

209

625

Fracture of neck

204

941

2.27

24.76

2.2

1.7

0.39

0.34

mg/l

0.67

115

464

Status epilepticus

131

495

2.80

24.71

2.0

1.8

0.43

0.33

mg/l

0.79

243

Paralytic ileus and intestinal obstruction

606

3877

1.59

24.68

1.8

1.6

0.38

0.32

mg/l

1.38

285

1816

Gonarthrosis

1688

7232

1.33

24.66

1.7

1.8

0.33

mg/l

0.09

833

3596

Other diseases of stomach and duodenum

183

806

2.36

24.64

2.0

1.6

0.41

0.30

mg/l

1.14

364

Ulcer of oesophagus

191

860

2.31

24.43

2.4

1.6

0.41

0.30

mg/l

2.00

114

395

Vascular disorders of the intestines

169

720

2.42

24.42

1.9

1.5

0.26

0.32

mg/l

0.85

305

Pain in thoracic spine

457

2746

1.71

24.40

1.9

1.6

0.27

0.31

mg/l

0.91

210

1266

Unspecified event, undetermined intent

134

521

2.80

24.39

2.3

1.7

0.32

mg/l

0.06

259

Complications of internal orthopaedic prosthetic devices, implants and grafts

494

3025

1.66

24.29

1.7

1.6

0.38

0.31

mg/l

1.68

254

1334

Hypoglycaemia, other or unspecified

242

1201

2.10

24.28

2.0

1.7

0.36

0.32

mg/l

0.41

131

572

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1588

11690

1.33

24.16

1.7

1.8

0.29

0.32

mg/l

1.02

773

5812

Internal derangement of knee

1095

7837

1.40

24.03

1.8

0.31

mg/l

0.14

553

3831

Mucosal proctocolitis

477

2920

1.69

24.02

1.5

1.8

0.23

0.31

mg/l

2.70

208

1452

Intestinal malabsorption

180

801

2.37

24.01

2.0

1.7

0.34

0.31

mg/l

0.29

381

Other bacterial intestinal infections

480

2931

1.67

24.00

2.1

1.7

0.35

0.31

mg/l

1.01

232

1376

Sequelae of intentional self-harm, assault and events of undetermined intent

174

4.71

23.86

3.1

1.6

0.38

0.29

mg/l

0.44

Focal epilepsy

621

4038

1.57

23.85

2.0

1.7

0.31

mg/l

0.03

326

1909

L04AA Selective immunosuppressants

695

4638

1.53

23.80

2.2

1.7

0.25

0.32

mg/l

2.59

284

2216

Inflammatory bowel disease, strict (require KELA)

816

5626

1.48

23.78

1.6

1.8

0.24

0.31

mg/l

3.10

369

2799

Superficial injury of hip and thigh

410

2408

1.74

23.75

1.8

1.6

0.37

0.31

mg/l

1.05

193

1075

Triptan medication for migraine, min. 3 purchases

1837

10674

1.30

23.62

1.7

0.26

0.30

mg/l

2.09

703

4912

Other neurotic disorders

150

618

2.54

23.62

1.7

1.6

0.33

0.36

mg/l

0.22

318

COPD, hospital admissions 3, with asthma pneumonia sepsis

571

3106

1.60

23.59

1.9

1.5

0.36

0.31

mg/l

1.22

296

1384

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1333

7288

1.36

23.56

1.7

1.6

0.26

0.28

mg/l

0.66

604

2880

Suppurative and unspecified otitis media

1337

8858

1.36

23.48

1.8

0.23

0.28

mg/l

4.02

609

4153

COPD, hospital admissions 1, only main diagnosis

738

4263

1.51

23.48

1.9

1.6

0.36

0.31

mg/l

1.78

390

1966

6-mercaptopurine

174

775

2.40

23.38

1.5

1.8

0.13

0.30

mg/l

8.85

381

Acute gastritis

208

987

2.18

23.32

2.3

1.6

0.40

0.30

mg/l

1.57

454

Autism

162

705

2.50

23.25

1.6

1.7

0.15

0.24

mg/l

3.25

328

Other Crohn's disease

283

1509

1.96

23.24

1.8

0.30

0.32

mg/l

0.15

133

730

Other arthritis (FG)

873

6109

1.45

23.21

1.9

1.7

0.32

0.30

mg/l

0.36

451

2883

Stroke, including SAH

1491

8090

1.34

23.20

1.7

0.34

0.32

mg/l

0.59

725

3973

Osteoporosis

521

2993

1.62

23.17

1.7

1.5

0.38

0.31

mg/l

1.76

220

1228

Stroke, excluding SAH

1378

7437

1.35

23.14

1.7

0.33

0.32

mg/l

0.31

663

3637

Trochanteric bursitis

350

1982

1.81

23.06

1.6

1.5

0.32

0.30

mg/l

0.21

151

867

Focal epilepsy, strict definition

565

3628

1.59

23.00

2.0

1.7

0.31

mg/l

0.05

305

1719

Migraine without aura and triptan purchases

576

3723

1.59

22.93

1.7

0.24

0.28

mg/l

1.06

183

1635

Disorders of calcium metabolism

184

838

2.28

22.92

2.3

1.6

0.43

0.32

mg/l

1.41

374

Other and unspecified psoriasis

226

1119

2.11

22.84

2.2

1.7

0.45

0.32

mg/l

2.20

124

537

Cardiodefibrillation

802

5522

1.47

22.82

1.7

0.35

0.33

mg/l

0.36

414

2684

Other predominantly sexually transmitted diseases, not elsewhere classified

610

4002

1.56

22.78

1.8

0.29

mg/l

0.02

290

1839

Need for other prophylactic measures

215

1049

2.15

22.75

1.6

1.8

0.32

mg/l

0.04

505

Diseases of the ear and mastoid process

3664

15336

1.21

22.71

1.8

0.28

0.31

mg/l

2.34

1686

7520

Enthesopathies of lower limb, excluding foot

650

4315

1.53

22.68

1.6

1.7

0.27

0.32

mg/l

1.33

302

2090

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

192

3784

0.48

22.51

1.4

1.6

0.29

0.32

mg/l

0.32

1774

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

970

6961

1.42

22.51

2.0

1.7

0.33

0.30

mg/l

0.98

519

3222

Ischaemic heart disease, wide definition

1977

9567

1.28

22.41

1.8

0.35

0.33

mg/l

0.71

1006

4866

Deforming dorsopathies

737

5028

1.49

22.34

1.8

1.7

0.31

mg/l

0.11

374

2310

Percutaneous Coronary Intervention

2102

10128

1.27

22.32

1.7

1.8

0.34

0.33

mg/l

0.28

1049

5156

Other enthesopathies

817

5688

1.46

22.30

1.7

0.29

0.32

mg/l

0.95

374

2751

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

961

6901

1.42

22.23

2.1

1.8

0.34

0.31

mg/l

0.82

549

3389

Fracture of femur

543

3118

1.59

22.23

1.8

1.6

0.31

mg/l

0.11

281

1349

Encephalopathy

143

4.61

22.23

3.2

1.4

0.25

0.35

mg/l

0.73

Coronary revascularization (ANGIO or CABG)

2105

10137

1.27

22.23

1.7

1.8

0.34

0.33

mg/l

0.35

1047

5161

Cerebral palsy and other paralytic syndromes

339

1932

1.81

22.10

1.9

1.7

0.34

0.31

mg/l

0.37

161

926

Other disorders of the musculoskeletal system and connective tissue

405

2423

1.71

22.09

2.0

1.7

0.28

0.32

mg/l

0.81

210

1144

Barrett oesophagus

165

733

2.36

22.02

2.0

1.6

0.48

0.31

mg/l

2.31

351

Progressive vascular leukoencephalopathy

289

3.20

21.91

1.6

1.3

0.32

0.27

mg/l

0.48

Other abnormal findings of blood chemistry

170

770

2.32

21.71

1.8

1.7

0.26

0.33

mg/l

1.05

377

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

189

892

2.19

21.47

1.7

1.6

0.34

0.32

mg/l

0.18

392

Childhood asthma (age<16), excluding more controls

566

2872

1.58

21.34

1.7

1.8

0.22

0.25

mg/l

0.91

250

1299

Lung diseases due to external agents

330

1881

1.79

21.31

2.4

1.6

0.38

0.32

mg/l

0.93

184

853

Cardiomyopathy (excluding other)

342

1974

1.78

21.27

1.8

1.7

0.39

0.32

mg/l

1.11

171

989

Motor disorders, excluding more controls

5.21

21.25

1.8

1.5

0.21

0.28

mg/l

0.46

Retention of urine

824

4660

1.45

21.25

1.8

1.6

0.29

0.32

mg/l

0.84

362

2281

Atherosclerosis, excluding cerebral and coronary sclerosis

809

4431

1.45

21.01

1.5

1.6

0.31

0.32

mg/l

0.33

395

2046

Ulcerative colitis, NAS

468

2946

1.63

21.01

1.6

1.8

0.25

0.31

mg/l

1.57

193

1443

Childhood asthma (age<16)

566

2883

1.57

21.00

1.7

1.8

0.22

0.25

mg/l

0.98

250

1308

Subjective visual disturbances

711

4889

1.48

20.90

1.8

1.7

0.25

0.30

mg/l

1.82

279

2232

Dementia, including avohilmo

840

4009

1.44

20.87

1.5

0.31

0.30

mg/l

0.17

352

1721

Superficial injury of shoulder and upper arm

394

2380

1.70

20.85

1.9

1.7

0.32

0.30

mg/l

0.23

203

1096

Dislocation, sprain and strain of joints and ligaments at neck level

543

3546

1.57

20.78

1.9

1.8

0.28

0.30

mg/l

0.41

255

1656

Thiamine deficiency

101

5.52

20.76

2.3

1.8

0.71

0.38

mg/l

1.68

Venous thromboembolism

1277

9302

1.34

20.73

1.8

1.7

0.33

0.31

mg/l

0.48

595

4420

Autism spe

155

697

2.41

20.69

1.6

1.7

0.15

0.23

mg/l

2.28

324

Major coronary heart disease event

2215

10654

1.25

20.67

1.8

0.35

0.33

mg/l

0.65

1119

5396

Pedal cyclist injured in transport accident

749

5220

1.47

20.66

2.4

1.8

0.35

0.30

mg/l

1.42

440

2509

Ventral hernia

603

4021

1.53

20.62

1.8

1.6

0.37

0.32

mg/l

0.99

295

1868

Viral and other specified intestinal infections, including avohilmo

1037

7349

1.38

20.51

1.9

1.8

0.29

0.26

mg/l

0.71

460

3446

Cluster headache, strict

150

663

2.39

20.45

1.8

0.25

0.34

mg/l

0.95

338

Open wound of hip and thigh

160

731

2.34

20.34

2.6

1.7

0.30

mg/l

0.03

363

Colitis, primary sclerosing, strict definition

243

3.60

20.22

1.6

0.15

0.29

mg/l

1.77

115

Fissure and fistula of anal and rectal regions

682

4685

1.48

20.15

1.8

1.7

0.29

0.31

mg/l

0.43

330

2252

Single delivery by forceps and vacuum extractor

244

2655

0.53

20.10

1.9

1.6

0.18

0.27

mg/l

2.73

1055

Bacterial intestinal infections, IBD co-morbidities

471

2995

1.60

20.04

2.1

1.6

0.37

0.31

mg/l

1.30

229

1376

Other disorders starting during childhood or adolescence

238

1250

1.98

19.98

1.9

1.7

0.18

0.21

mg/l

0.47

100

531

Brachial plexus disorders

310

1777

1.80

19.96

1.7

0.32

0.31

mg/l

0.12

149

845

Cluster headache, wide

154

696

2.33

19.88

1.8

0.25

0.34

mg/l

1.11

355

Mental and behavioural disorders due to use of volatile solvents

6.97

19.82

2.8

1.5

0.35

0.39

mg/l

0.13

Other complications of surgical and medical care, not elsewhere classified

293

1657

1.82

19.69

1.8

1.6

0.30

mg/l

0.02

127

756

Rheumatism, unspecified

310

1778

1.78

19.66

1.6

1.5

0.30

mg/l

0.03

129

767

Fungal Sepsis

130

548

2.48

19.56

2.0

1.6

0.36

0.29

mg/l

0.52

249

Acne, including avohilmo

905

5305

1.41

19.54

1.8

0.19

0.25

mg/l

3.59

349

2293

Ischaemic Stroke, excluding all haemorrhages

1243

6916

1.34

19.54

1.6

1.7

0.31

0.32

mg/l

0.50

589

3353

Acute alcohol intoxication ICD-9

100

374

2.81

19.28

2.7

1.4

0.37

0.27

mg/l

1.04

171

Other follicular disorders

285

1616

1.83

19.22

2.0

1.8

0.32

mg/l

0.05

127

758

Leisure time condition

549

3652

1.54

19.20

2.4

1.7

0.37

0.30

mg/l

2.06

292

1695

Focal epilepsy, mode (most common among epilepsy diagnosis)

525

3457

1.55

19.18

2.0

1.7

0.32

0.31

mg/l

0.14

278

1635

Fracture of forearm

1524

10715

1.29

19.09

1.8

1.7

0.32

0.29

mg/l

1.54

773

4834

Emergency coronary revascularization (for ACS)

2188

10704

1.24

19.08

1.7

1.8

0.34

0.33

mg/l

0.15

1081

5430

Symptoms and signs involving speech and voice

818

5865

1.41

19.03

1.6

0.33

0.30

mg/l

0.55

294

2675

Pure hyperglyceridaemia

323

2.98

18.96

1.8

0.27

0.35

mg/l

0.71

153

Epileptic seizures related to alcohol

127

4.80

18.93

3.5

1.5

0.51

0.35

mg/l

0.98

Fibroblastic disorders

549

3655

1.53

18.91

1.9

1.6

0.31

0.32

mg/l

0.10

273

1731

Conjunctivitis (acute, non atopic), including avohilmo

3110

15767

1.20

18.90

1.7

1.8

0.29

0.31

mg/l

1.11

1407

7728

Stomatitis and related lesions

604

4110

1.50

18.89

1.9

1.7

0.33

0.29

mg/l

0.85

289

1878

Cardiomyopathies, Primary/intrinsic

322

1891

1.75

18.89

1.7

0.38

0.32

mg/l

0.70

155

952

Open wound of shoulder and upper arm

102

395

2.80

18.77

2.5

1.6

0.49

0.32

mg/l

1.39

185

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1571

9596

1.28

18.57

1.7

1.6

0.28

0.30

mg/l

0.63

720

4073

Other diseases of oesophagus

234

1257

1.91

18.50

2.3

1.6

0.37

0.28

mg/l

1.61

131

571

Sequelae with surgical and medical care as external cause

512

3381

1.54

18.46

1.8

1.6

0.32

0.31

mg/l

0.14

247

1560

Exposure to other and unspecified inanimate mechanical forces

294

1707

1.79

18.31

2.0

1.8

0.29

0.31

mg/l

0.29

143

848

Bacterial pneumoniae

1059

6965

1.35

18.31

1.9

1.7

0.34

0.31

mg/l

0.94

535

3321

Second line medication for Crohn's disease

1659

13208

1.27

18.22

1.6

1.8

0.28

0.31

mg/l

1.54

749

6335

Thiazolidinediones

263

1473

1.83

18.20

1.8

1.6

0.30

0.33

mg/l

0.39

121

698

Other systemic involvement of connective tissue (FG)

590

3946

1.49

18.07

1.5

1.6

0.28

0.29

mg/l

0.14

228

1713

Diplopia

366

2253

1.66

18.00

2.0

1.6

0.32

0.30

mg/l

0.18

173

1047

Disorders of magnesium metabolism

112

4.67

17.99

2.5

1.7

0.59

0.38

mg/l

1.05

Implicit fungal Sepsis

118

496

2.49

17.91

1.9

1.6

0.37

0.29

mg/l

0.54

225

Other disorders of skin and subcutaneous tissue

1877

12789

1.25

17.86

1.7

0.32

0.31

mg/l

0.14

834

6053

Other and unspecified intracranial injuries

114

475

2.54

17.78

3.0

1.7

0.28

0.32

mg/l

0.38

231

Bacterial pneumonia (organism specified)

1110

7624

1.33

17.66

1.9

1.7

0.34

0.31

mg/l

1.17

555

3608

Other viral diseases, including avohilmo

1290

9923

1.31

17.63

1.8

0.27

0.30

mg/l

1.12

549

4732

Temporomandibular joint disorders, including avohilmo

1392

10567

1.29

17.58

1.7

0.24

0.28

mg/l

2.27

545

4716

Asthma/COPD (KELA code 203)

2855

16027

1.20

17.54

1.7

1.8

0.29

0.30

mg/l

0.48

1371

7613

Other condition

469

3084

1.56

17.47

2.0

1.8

0.32

0.31

mg/l

0.16

258

1500

D07AA Corticosteroids, weak (group I)

497

3302

1.54

17.44

1.9

1.7

0.36

0.28

mg/l

1.90

248

1479

ILD medications: azathioprine

464

3043

1.56

17.44

1.6

1.8

0.28

0.30

mg/l

0.27

188

1473

Asthma and allergy, excluding more controls

429

2728

1.59

17.39

1.6

0.24

0.27

mg/l

0.88

179

1163

IBD (strict) with PSC

234

3.43

17.36

1.7

1.6

0.12

0.29

mg/l

3.90

111

Phlebitis and thrombophlebitis (not including DVT)

576

3947

1.48

17.32

2.0

1.7

0.30

0.32

mg/l

0.42

278

1909

Other and unspecified injuries of lower leg

265

1516

1.81

17.29

1.9

1.7

0.31

0.30

mg/l

0.20

118

689

Disorders of continuity of bone

319

1921

1.71

17.22

2.0

1.7

0.35

0.31

mg/l

0.65

181

894

Perineal laceration during delivery

258

3567

0.57

17.21

1.6

0.25

mg/l

0.03

1405

Other fall from one level to another

719

5142

1.42

17.19

2.1

1.8

0.35

0.30

mg/l

1.41

393

2475

Asthma and allergy

429

2737

1.58

17.12

1.6

0.24

0.28

mg/l

0.93

179

1170

Cholecystitis

306

1818

1.71

17.11

2.0

1.6

0.40

0.29

mg/l

1.88

130

856

Other injuries of upper limb, level unspecified

229

3.34

17.03

2.1

1.5

0.32

0.30

mg/l

0.11

100

Non-allergic asthma (mode), excluding more controls

464

3026

1.54

16.91

1.8

1.6

0.27

0.30

mg/l

0.51

224

1328

Meniscus derangement

1459

7619

1.28

16.82

1.8

0.32

mg/l

0.04

741

3796

Disorders of lacrimal system

1081

8111

1.33

16.76

1.6

1.7

0.26

0.31

mg/l

2.65

427

3696

Injury of unspecified body region

235

1309

1.85

16.76

2.2

1.7

0.35

0.30

mg/l

0.77

115

606

Coxarthrosis

1170

5779

1.32

16.59

1.7

0.33

mg/l

0.03

564

2851

Spondylolisthesis/Spondylolysis

444

2918

1.55

16.40

1.8

1.6

0.36

0.32

mg/l

0.72

233

1364

Mouth breathing

1143

8818

1.31

16.34

1.7

1.8

0.28

0.33

mg/l

2.12

563

4492

Alzheimer’s disease (Late onset), excluding more controls

188

615

2.01

16.34

1.3

1.2

0.31

0.27

mg/l

0.36

221

Candidiasis

400

2576

1.59

16.32

1.7

1.6

0.35

0.31

mg/l

0.70

171

1127

199

3.50

16.28

1.6

0.19

0.27

mg/l

0.72

Hidradenitis suppurativa

161

805

2.11

16.21

2.1

1.7

0.30

0.31

mg/l

0.02

382

Azathioprine

464

3098

1.53

16.09

1.6

1.8

0.28

0.30

mg/l

0.38

188

1494

Other disorders of lacrimal gland

905

6779

1.35

16.07

1.6

1.7

0.26

0.31

mg/l

2.59

363

3071

Enterocolitis due to Clostridium difficile

255

1469

1.78

16.06

2.2

1.6

0.39

0.31

mg/l

1.26

125

639

Mycoses

767

5608

1.39

16.03

1.7

0.32

0.31

mg/l

0.25

358

2618

Ulcerative colitis (strict) with PSC

182

3.69

16.01

1.6

1.5

0.12

0.31

mg/l

2.73

Coronary atherosclerosis

1543

7752

1.27

15.95

1.7

0.35

0.33

mg/l

0.83

787

3971

Benign neoplasm of other and ill-defined parts of digestive system

405

2627

1.57

15.92

1.8

1.6

0.32

0.31

mg/l

0.24

189

1180

Osteonecrosis

184

966

1.97

15.86

2.2

1.7

0.40

0.36

mg/l

0.39

105

446

Hemiplegia

148

719

2.14

15.84

1.9

1.7

0.39

0.35

mg/l

0.32

338

Carpal tunnel syndrome

1556

10816

1.26

15.83

1.7

0.33

0.32

mg/l

0.23

729

5182

Excessive, frequent and irregular menstruation

993

3976

1.35

15.83

1.6

0.24

0.27

mg/l

0.96

365

1614

Anogenital herpesviral [herpes simplex] infection

239

1372

1.81

15.56

2.0

1.6

0.24

0.29

mg/l

1.03

116

608

Acute pharyngitis

574

3983

1.46

15.56

1.9

1.8

0.27

0.30

mg/l

0.65

259

1948

Gonarthrosis [arthrosis of knee](FG)

1922

9033

1.23

15.55

1.7

1.8

0.32

0.33

mg/l

0.19

957

4495

Acute suppurative otitis media

991

7051

1.33

15.51

1.9

1.8

0.24

0.27

mg/l

1.74

466

3292

Crohn's disease NAS

227

1287

1.83

15.42

1.8

0.31

0.32

mg/l

0.11

106

625

Toxic effect of carbon monoxide

310

2.83

15.33

3.1

1.6

0.47

0.34

mg/l

1.00

149

Chronic laryngitis and laryngotracheitis

362

2312

1.60

15.31

1.8

1.6

0.37

0.32

mg/l

0.69

171

1046

Cardiomyopathy, other and unspecified

207

1141

1.87

15.27

1.6

1.7

0.37

0.33

mg/l

0.46

554

All influenza

711

5175

1.39

15.26

1.9

1.7

0.27

0.30

mg/l

0.77

316

2501

Other viral diseases

967

7354

1.33

15.25

1.8

0.25

0.30

mg/l

1.66

422

3528

Disorders of muscles

298

1820

1.68

15.23

1.7

1.6

0.30

0.31

mg/l

0.11

139

875

Open wound of neck

172

3.65

15.19

3.8

1.5

0.30

0.32

mg/l

0.08

Non-allergic asthma (mode)

464

3100

1.51

15.13

1.8

1.6

0.27

0.30

mg/l

0.53

224

1363

Haemorrhage, not elsewhere classified

101

427

2.45

15.13

1.7

1.5

0.30

0.29

mg/l

0.11

194

Any death

1007

9147

0.76

15.11

1.8

1.7

0.43

0.32

mg/l

6.61

552

4485

Bacterial pneumonia, not elsewhere classified

968

6469

1.33

15.10

1.9

1.7

0.34

0.30

mg/l

1.08

486

3091

Any event in hilmo or specialist outpatient

9.35

15.10

1.7

0.40

0.22

mg/l

—

Cervicocranial syndrome

280

1686

1.70

15.06

1.6

0.29

mg/l

0.03

120

738

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

512

3532

1.48

15.00

1.5

1.6

0.25

0.27

mg/l

0.44

188

1362

Other obstetric conditions, not elsewhere classified

1026

4946

1.33

14.99

1.7

1.6

0.24

0.26

mg/l

0.44

391

1962

Benign neoplasms

3151

14690

1.18

14.98

1.8

0.32

0.30

mg/l

0.95

1475

7208

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

545

3815

1.46

14.93

1.5

1.8

0.23

0.31

mg/l

3.31

243

1877

Car occupant injured in noncollision transport accident

155

789

2.07

14.92

2.6

1.7

0.26

0.31

mg/l

0.59

376

Other or unspecified ileus, impaction or obstruction

400

2622

1.55

14.92

1.8

1.6

0.41

0.31

mg/l

1.96

184

1221

Benign neoplasm: Rectum, anus and anal canal

451

3036

1.51

14.91

1.8

1.6

0.34

0.32

mg/l

0.32

212

1409

Chronic diseases of tonsils and adenoids

2440

12940

1.20

14.89

1.8

0.29

0.31

mg/l

0.68

1168

6260

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

588

4178

1.44

14.80

1.5

1.8

0.24

0.31

mg/l

3.04

266

2071

Unspecified haematuria

1011

6314

1.32

14.76

1.7

0.32

mg/l

0.04

454

3160

Conjunctivitis

2297

15524

1.20

14.76

1.8

0.28

0.30

mg/l

1.34

992

7330

Pedestrian injured in transport accident

223

1273

1.81

14.75

2.1

1.7

0.28

0.31

mg/l

0.38

127

610

Neuralgia and neuritis, unspecified

159

816

2.02

14.69

1.8

1.6

0.23

0.31

mg/l

1.56

395

Abscess of anal and rectal regions

292

1796

1.67

14.66

2.0

1.8

0.30

0.32

mg/l

0.20

183

921

Other disorders of veins

963

7255

1.32

14.63

1.5

1.6

0.33

0.31

mg/l

0.33

404

3377

Benign neoplasm: Rectum

411

2727

1.53

14.61

1.9

1.6

0.33

mg/l

0.07

201

1270

Vitamin D deficiency

329

2.70

14.59

2.4

1.6

0.35

0.28

mg/l

0.44

153

Cerebral cysts

193

1065

1.88

14.35

2.1

1.7

0.30

mg/l

0.03

506

Problems related to social environment

100

433

2.42

14.35

2.5

1.6

0.31

mg/l

0.01

193

Injury of muscle and tendon at wrist and hand level

427

2877

1.52

14.28

2.4

1.7

0.38

0.33

mg/l

1.06

261

1463

Discitis, unspecified

213

3.11

14.22

2.4

1.5

0.35

0.39

mg/l

0.16

110

Cramp and spasm

165

870

1.98

14.21

1.9

1.7

0.26

0.32

mg/l

0.84

421

Reimbursement for rheumatic diseases

1447

11618

1.25

14.16

1.7

0.30

0.31

mg/l

0.39

612

5445

Other and unspecified injuries of ankle and foot

166

879

1.97

14.14

2.0

1.6

0.29

0.30

mg/l

0.21

410

Diagnoses used for exclusion with ILD

607

4361

1.41

14.14

2.0

1.7

0.34

0.32

mg/l

0.26

297

2119

DVT of lower extremities and pulmonary embolism

915

6960

1.32

14.14

1.8

1.7

0.34

0.31

mg/l

0.67

434

3277

Benign neoplasm: Caecum

247

1465

1.73

14.12

1.7

1.6

0.32

0.33

mg/l

0.10

116

642

Speech disturbances, not elsewhere classified

223

1286

1.78

14.12

1.7

1.6

0.37

0.32

mg/l

0.53

609

Cluster headache, strict, including avohilmo

191

1059

1.88

14.11

1.9

1.7

0.25

0.31

mg/l

0.89

510

Degenerative diseases of the nervous system

572

2896

1.43

14.08

1.8

1.4

0.39

0.29

mg/l

3.36

292

1175

Systemic connective tissue disorders

779

5826

1.35

14.04

1.5

1.6

0.28

0.30

mg/l

0.42

314

2572

Other and unspecified nerve root and plexus disorders, also in other diseases

586

4196

1.42

14.03

2.0

1.8

0.33

mg/l

0.08

298

2087

Ulcerative colitis (strict definition, require KELA)

551

3912

1.44

13.98

1.5

1.8

0.23

0.31

mg/l

3.32

245

1933

Biomechanical lesions, not elsewhere classified

146

741

2.04

13.96

1.9

1.7

0.24

0.34

mg/l

1.88

341

Other symptoms and signs involving the digestive system and abdomen

365

2384

1.55

13.91

1.7

1.5

0.32

0.28

mg/l

0.54

143

1050

Sequelae of cerebrovascular disease

715

4497

1.37

13.90

1.5

1.6

0.34

0.31

mg/l

0.62

330

2092

Disorders of conjunctiva

2496

16430

1.18

13.90

1.8

0.28

0.30

mg/l

1.25

1083

7795

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

243

1444

1.73

13.88

1.9

1.7

0.37

0.33

mg/l

0.50

131

688

Viral pneumonia

360

2352

1.56

13.85

2.0

1.6

0.24

0.31

mg/l

2.20

161

1127

Intestinal stricture

693

5103

1.37

13.84

1.9

1.7

0.40

0.31

mg/l

2.33

323

2410

Other local infections of skin and subcutaneous tissue

293

1828

1.64

13.82

1.9

1.7

0.26

0.32

mg/l

1.14

124

886

Injury of intra-abdominal organs

111

515

2.29

13.74

2.6

1.7

0.25

0.29

mg/l

0.44

264

COPD-related respiratory insufficiency

238

1408

1.72

13.67

1.9

1.5

0.35

0.33

mg/l

0.16

111

633

Other embolism and thrombosis

314

1995

1.61

13.64

2.1

1.6

0.37

0.31

mg/l

0.95

159

937

L04AC Interleukin inhibitors

242

1449

1.73

13.63

2.0

1.8

0.36

0.32

mg/l

0.42

123

712

Dysplasia of cervi uteri

624

3162

1.41

13.61

1.8

1.6

0.26

0.29

mg/l

0.64

287

1299

Cluster headache, wide,, including avohilmo

195

1100

1.85

13.60

1.9

1.7

0.25

0.32

mg/l

1.08

532

Triptan medication for migraine, single purchase ok

2388

13703

1.19

13.59

1.7

1.8

0.27

0.31

mg/l

2.76

980

6695

Migraine, single triptan purchase ok & required. ICD-code if available is included

2388

13703

1.19

13.59

1.7

1.8

0.27

0.31

mg/l

2.76

980

6695

Superficial injury of neck

101

454

2.39

13.58

2.0

1.7

0.43

0.31

mg/l

0.89

217

Type 1 diabetes

725

5392

1.36

13.56

1.8

0.30

0.31

mg/l

0.01

347

2702

Dependent personality disorder

311

2.68

13.56

1.7

0.34

0.35

mg/l

0.03

142

Other shoulder lesions

280

1736

1.65

13.56

1.9

1.7

0.32

0.31

mg/l

0.17

122

827

Contact with sharp object, undetermined intent

119

572

2.22

13.55

2.1

1.8

0.35

0.34

mg/l

0.11

290

!Aliquae complicationes praecoces traumatis

159

843

1.97

13.51

2.4

1.7

0.33

0.32

mg/l

0.08

422

Early complications of trauma

159

843

1.97

13.51

2.4

1.7

0.33

0.32

mg/l

0.08

422

Urticaria and erythema

1018

7946

1.30

13.50

1.6

1.7

0.33

0.30

mg/l

0.87

420

3623

Pacemaker

683

4672

1.37

13.48

1.5

1.6

0.29

0.31

mg/l

0.53

312

2139

Endocarditis

108

496

2.27

13.47

2.4

1.6

0.34

mg/l

0.01

246

Diseases of tongue

143

727

2.02

13.47

1.7

1.6

0.41

0.30

mg/l

1.24

320

Other cataract

983

5648

1.31

13.38

1.7

0.33

0.31

mg/l

0.50

445

2745

Disorders of oesophagus in diseases classified elsewhere

237

2.89

13.33

1.8

1.6

0.32

0.30

mg/l

0.14

104

Other diseases of blood and blood-forming organs, wide

548

3914

1.42

13.31

1.8

1.7

0.33

0.31

mg/l

0.20

240

1826

Other neurological diseases

1725

11038

1.22

13.28

1.7

0.31

0.32

mg/l

0.17

735

5322

Hypocalcemia

375

2.49

13.25

2.7

1.6

0.45

0.34

mg/l

0.87

173

Disorders of synovium and tendon

1434

9869

1.24

13.24

1.7

0.31

mg/l

0.05

654

4791

Other sexually transmitted chlamydial diseases

275

1716

1.66

13.24

1.7

1.8

0.27

mg/l

0.02

128

775

Other disorders of bone

587

4251

1.41

13.22

1.8

1.7

0.30

0.31

mg/l

0.23

278

2049

Sequelae of injuries of lower limb

290

1828

1.63

13.20

1.9

1.8

0.29

0.32

mg/l

0.45

150

899

Neoplasms

2681

12022

1.18

13.17

1.9

1.8

0.31

0.29

mg/l

0.91

1308

5926

Accidental poisoning by and exposure to alcohol

404

2.45

13.11

2.4

1.7

0.35

0.29

mg/l

0.60

180

Diseases of external ear

937

7268

1.30

13.09

1.7

0.25

0.31

mg/l

2.99

388

3457

Operations 2 for CAVS

508

3445

1.43

13.08

1.6

1.5

0.29

0.30

mg/l

0.35

227

1524

Calcific aortic valvular stenosis, diagnosis (helper)

508

3445

1.43

13.08

1.6

1.5

0.29

0.30

mg/l

0.35

227

1524

Special screening examination for other diseases and disorders

302

1918

1.60

13.07

1.9

1.6

0.25

0.31

mg/l

1.13

145

894

Contact with other sharp object(s)

271

1690

1.66

13.07

2.2

1.8

0.33

0.30

mg/l

0.43

154

840

Contusion of ankle

160

861

1.94

13.03

1.7

1.6

0.30

0.29

mg/l

0.05

407

Other disorders of eye and adnexa

403

2733

1.50

13.03

1.8

1.7

0.28

0.30

mg/l

0.30

177

1241

Intentional self-harm by smoke, fire and flames

7.20

13.02

3.0

1.5

0.43

0.42

mg/l

0.02

Calcific aortic valvular stenosis, operated

508

3449

1.43

13.00

1.6

1.5

0.29

0.31

mg/l

0.35

227

1526

Calcific aortic valvular stenosis

508

3449

1.43

13.00

1.6

1.5

0.29

0.31

mg/l

0.35

227

1526

Deviated nasal septum

959

7469

1.30

12.92

1.8

1.9

0.31

0.33

mg/l

0.45

512

3883

Other systemic involvement of connective tissue

600

4369

1.39

12.91

1.5

1.6

0.27

0.30

mg/l

0.38

233

1865

Hypotension due to drugs

166

3.28

12.86

2.0

1.4

0.39

0.31

mg/l

0.40

Calcific aortic valvular stenosis, including rheumatic fever

508

3456

1.43

12.78

1.6

1.5

0.29

0.31

mg/l

0.36

227

1527

Acute hepatitis B

101

4.42

12.78

2.3

1.7

0.31

mg/l

0.00

Burns and corrosions of multiple and unspecified body regions

446

2.34

12.75

2.6

1.7

0.31

0.33

mg/l

0.18

230

Other blood glucose lowering drugs, excl. Insulins

308

1979

1.58

12.70

1.7

1.6

0.27

0.33

mg/l

1.25

132

924

Disorders in reading

392

2.46

12.67

1.8

1.6

0.36

0.25

mg/l

0.45

179

Pervasive developmental disorders excl. Autism + Asperger

254

2.83

12.66

1.4

1.7

0.16

0.24

mg/l

1.03

116

Other and unspecified local infections of skin and subcutaneous tissue

274

1721

1.63

12.62

1.9

1.7

0.26

0.32

mg/l

0.83

115

824

Extreme obesity with alveolar hypoventilation

120

590

2.12

12.61

1.9

1.7

0.30

0.37

mg/l

0.68

292

Epidural haemorrhage

123

3.70

12.60

2.4

1.7

0.59

0.33

mg/l

1.41

Pedal cyclist injured in noncollision transport accidents

376

2538

1.52

12.56

2.4

1.8

0.36

0.32

mg/l

0.66

226

1244

Emphysema

168

923

1.86

12.56

2.0

1.7

0.29

0.34

mg/l

0.91

102

428

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

989

4855

1.30

12.54

1.7

1.6

0.24

0.26

mg/l

0.35

374

1927

Examination and encounter for administrative purposes

203

1182

1.76

12.48

3.1

1.6

0.27

0.30

mg/l

0.34

114

575

Hypothermia

301

2.62

12.38

3.4

1.6

0.30

0.32

mg/l

0.14

141

L04AX Other immunosuppressants

1534

12655

1.22

12.32

1.6

1.8

0.29

0.31

mg/l

0.89

702

6051

Dilated cardiomyopathy

294

1888

1.59

12.32

1.7

0.37

0.33

mg/l

0.51

143

958

Lesion of radial nerve

119

589

2.10

12.31

2.6

1.7

0.43

0.35

mg/l

0.66

300

Overexertion and strenuous or repetitive movements

315

2060

1.57

12.27

1.8

0.34

0.32

mg/l

0.20

172

1020

Amputation

215

1276

1.72

12.26

1.5

1.6

0.26

0.33

mg/l

1.50

108

592

Amenorrhoea

223

1342

1.71

12.24

1.8

1.6

0.30

0.27

mg/l

0.23

505

Epileptic seizures related to drugs

5.21

12.22

2.7

1.5

0.33

0.35

mg/l

0.05

Postmenopausal bleeding

473

1713

1.46

12.20

1.5

1.6

0.34

0.33

mg/l

0.03

177

750

Atopic dermatitis, strict definition with reimbursement

989

7492

1.28

12.16

1.6

1.8

0.30

0.28

mg/l

0.39

450

3417

Diseases of salivary glands

859

6663

1.30

12.07

1.8

1.7

0.30

0.31

mg/l

0.02

362

3139

Other disorders of penis

335

2229

1.54

12.01

1.9

2.0

0.24

0.35

mg/l

4.65

188

1262

Metatarsalgia

248

1540

1.65

11.95

1.6

0.36

0.29

mg/l

0.72

697

214

2.95

11.90

2.8

1.7

0.32

0.30

mg/l

0.08

103

Other and unspecified injuries of wrist and hand

142

758

1.95

11.88

2.2

1.6

0.24

0.30

mg/l

0.99

337

Infective dermatitis

302

1971

1.56

11.79

2.2

1.7

0.43

0.30

mg/l

2.83

184

915

Benign neoplasm: Transverse colon

249

1555

1.64

11.74

2.0

1.6

0.36

0.34

mg/l

0.16

131

720

Other respiratory diseases principally affecting the interstitium

357

2412

1.50

11.69

1.7

1.5

0.36

0.31

mg/l

0.72

170

1075

Pulmonary heart disease, diseases of pulmonary circulation

665

4997

1.34

11.68

1.7

0.36

0.32

mg/l

0.98

314

2321

Tic disorders

251

2.76

11.65

2.3

1.6

0.17

0.24

mg/l

0.78

111

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

166

2866

0.57

11.61

1.7

1.5

0.35

0.32

mg/l

0.21

1307

Diseases of peritoneum

243

1513

1.64

11.61

2.4

1.7

0.34

mg/l

0.05

124

702

Peripheral artery operations in Hilmo

248

1549

1.63

11.56

1.5

1.6

0.27

0.32

mg/l

0.90

134

717

Magnesium deficiency

5.71

11.51

1.9

1.7

0.53

0.43

mg/l

0.24

Acute hepatitis B, including avohilmo

109

4.04

11.45

2.3

1.6

0.31

0.30

mg/l

0.02

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

418

2929

1.45

11.42

1.9

1.7

0.27

0.32

mg/l

1.56

217

1391

Prurigo nodularis

325

2.45

11.33

1.8

1.6

0.43

0.34

mg/l

0.51

148

Other enthesopathy of foot (+metatarsalgia)

266

1702

1.59

11.33

1.7

1.6

0.35

0.30

mg/l

0.60

104

758

Crohn's disease of small intestine

234

1458

1.65

11.32

1.6

1.8

0.24

0.31

mg/l

1.14

699

Hypopituitarism

258

1647

1.62

11.29

1.9

0.25

0.32

mg/l

1.48

106

864

Pedal cyclist injured in other and unspecified transport accidents

350

2382

1.50

11.27

2.4

1.8

0.36

0.30

mg/l

0.85

211

1161

Dementia

705

3641

1.33

11.26

1.5

0.29

0.30

mg/l

0.12

300

1529

Colonic or urogenital fistula

710

5424

1.33

11.25

1.8

1.7

0.30

0.32

mg/l

0.35

346

2612

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

359

2.39

11.24

2.1

1.5

0.23

0.25

mg/l

0.15

150

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

4.14

11.21

1.3

1.2

0.11

0.15

mg/l

—

Benign neoplasm: Ascending colon

301

1986

1.54

11.14

1.8

1.6

0.30

0.33

mg/l

0.45

145

893

Contact with heat and hot substances

185

1091

1.76

11.11

2.2

1.7

0.30

0.32

mg/l

0.19

110

525

Ovarian cyst

835

3692

1.31

11.06

1.7

1.6

0.26

0.28

mg/l

0.35

325

1505

Specific development disorders of speech and language

215

1272

1.68

11.01

1.9

1.7

0.22

0.24

mg/l

0.28

578

Mixed hyperlipidaemia

109

544

2.07

11.01

1.8

1.7

0.37

0.33

mg/l

0.34

255

Amputation of toe

164

934

1.80

10.98

1.5

1.6

0.23

0.35

mg/l

3.36

441

Psoriatic and enteropathic arthropathies

325

2189

1.51

10.98

1.8

0.28

0.32

mg/l

0.62

171

1072

Salpingitis and oophoritis

362

2487

1.48

10.96

1.6

1.5

0.28

0.31

mg/l

0.65

153

1016

Mental and behavioural disorders due to cocaine

6.95

10.93

4.5

1.4

0.28

0.45

mg/l

0.53

Glomerular diseases

459

3298

1.41

10.91

1.7

1.8

0.30

0.32

mg/l

0.38

187

1639

Labour and delivery complicated by fetal stress [distress]

451

4070

0.71

10.91

1.7

1.6

0.24

0.26

mg/l

0.32

163

1647

Other respiratory disorders and diseases

403

2825

1.44

10.91

1.8

1.6

0.33

0.31

mg/l

0.39

192

1296

Other diseases of the respiratory system

403

2825

1.44

10.91

1.8

1.6

0.33

0.31

mg/l

0.39

192

1296

All dysplastic lesions of the cervix uteri, vagina or vulva

756

5704

1.31

10.86

1.7

1.6

0.27

0.28

mg/l

0.16

346

2239

Pruritus

288

1895

1.55

10.83

1.5

1.6

0.34

0.29

mg/l

0.56

124

820

Other orthopaedic follow-up care

162

925

1.80

10.82

2.2

1.7

0.29

0.30

mg/l

0.17

103

446

Diabetic maculopathy, excluding more controls

287

1889

1.55

10.82

1.8

0.27

0.30

mg/l

0.53

123

934

Crohn's disease of large intestine

174

1018

1.77

10.77

1.7

0.30

0.32

mg/l

0.15

501

100

491

2.15

10.76

2.7

1.6

0.36

0.32

mg/l

0.33

242

Gender identity disorders

317

2.48

10.76

1.8

1.5

0.15

0.23

mg/l

1.15

142

Peripheral arterial reconstruction

299

1983

1.53

10.73

1.4

1.5

0.31

0.32

mg/l

0.13

155

882

Other female pelvic inflammatory diseases

335

2279

1.49

10.69

1.6

1.5

0.24

0.29

mg/l

1.09

133

887

Single spontaneous delivery

619

4332

0.75

10.66

1.6

1.5

0.25

0.26

mg/l

0.29

223

1667

Otitis externa

636

4826

1.34

10.64

1.7

0.25

0.31

mg/l

2.67

276

2286

Panniculitis affecting regions of neck and back

106

532

2.06

10.58

1.9

1.7

0.28

0.34

mg/l

0.62

251

Crohn disease (strict definition, require KELA)

226

1422

1.64

10.57

1.7

1.8

0.28

0.31

mg/l

0.37

103

681

Viral infections characterized by skin and mucous membrane lesions

1160

9460

1.24

10.56

1.9

1.8

0.32

0.31

mg/l

0.10

538

4619

Other arrhythmias

1686

10599

1.20

10.55

1.6

1.8

0.27

0.31

mg/l

1.80

735

5113

Injury of nerves at wrist and hand level

139

768

1.89

10.53

2.0

1.7

0.33

0.31

mg/l

0.18

384

Foreign body in alimentary tract

162

936

1.79

10.45

2.2

1.7

0.38

0.31

mg/l

0.70

461

Crohn disease (strict definition, require KELA, min 2 HDR)

223

1405

1.64

10.39

1.7

1.8

0.28

0.31

mg/l

0.31

102

670

Suppurative and necrotic conditions of lower respiratory tract

152

864

1.81

10.34

2.3

1.7

0.41

0.33

mg/l

0.82

428

Olecranon bursitis

183

1097

1.72

10.31

2.3

1.7

0.42

0.31

mg/l

1.45

118

583

Schizoid personality disorder

355

2.35

10.29

2.6

1.8

0.29

0.35

mg/l

0.37

194

Urticaria

829

6538

1.28

10.29

1.6

1.7

0.31

0.30

mg/l

0.15

343

2954

Hepatomegaly and splenomegaly, not elsewhere classified

146

3.19

10.26

2.2

1.6

0.15

0.31

mg/l

1.61

Abnormal findings on diagnostic imaging of central nervous system

155

890

1.80

10.24

1.8

1.7

0.35

0.33

mg/l

0.14

419

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

113

586

1.99

10.23

1.7

1.4

0.33

mg/l

0.00

251

Arthropathies in other diseases classified elsewhere

104

526

2.05

10.19

1.7

0.37

0.33

mg/l

0.27

265

Maternal care for other conditions predominantly related to pregnancy

595

4386

1.34

10.18

1.6

0.24

0.28

mg/l

0.93

225

1779

Other disorders of electrolyte and fluid balance, not elsewhere classified

3.81

10.18

1.5

1.6

0.49

0.32

mg/l

0.52

Conduction disorders

611

3695

1.34

10.17

1.6

0.32

0.31

mg/l

0.10

267

1767

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

461

3356

1.40

10.15

2.0

1.7

0.26

0.32

mg/l

1.91

241

1615

Other diseases of pleura

932

6465

1.26

10.14

1.9

1.6

0.33

0.32

mg/l

0.29

471

3051

Misadventures to patients during surgical and medical care

342

2363

1.47

10.13

1.8

1.6

0.33

0.30

mg/l

0.50

165

1060

Gonococcal infection, including avohilmo

128

698

1.91

10.12

1.7

0.25

0.32

mg/l

0.81

328

Pulmonary embolism

611

4636

1.33

10.12

1.8

1.7

0.36

0.32

mg/l

0.85

284

2172

Acute peritonitis

165

966

1.75

10.11

2.7

1.7

0.38

0.35

mg/l

0.21

467

Coxarthrosis [arthrosis of hip](FG)

1226

6915

1.23

10.09

1.6

1.7

0.33

mg/l

0.01

585

3388

Other viral diseases, not elsewhere classified, including avohilmo

831

6535

1.28

10.08

1.7

1.8

0.27

0.30

mg/l

0.53

364

3099

Abnormal blood-pressure reading, without diagnosis

129

703

1.89

10.08

1.8

1.6

0.32

0.31

mg/l

0.10

328

Deficiency of other B group vitamins

249

2.56

10.07

2.0

1.5

0.22

0.33

mg/l

1.10

111

Dentofacial anomalies [including malocclusion]

2150

14516

1.17

10.07

1.7

1.8

0.25

0.31

mg/l

4.81

919

6948

Other and unspecified disorders of adult personality and behaviour

123

3.51

10.04

2.7

1.5

0.22

0.28

mg/l

0.33

Amiodarone users

220

1388

1.62

10.03

1.6

0.28

0.34

mg/l

0.80

103

648

Pilonidal cyst

324

2230

1.49

10.02

1.9

0.27

0.32

mg/l

0.99

160

1169

Ulcerative ileocolitis

144

817

1.83

10.01

1.7

1.8

0.27

0.31

mg/l

0.39

412

Appendectomy

1889

15397

1.18

10.01

1.7

1.8

0.29

0.31

mg/l

0.59

903

7422

Pulmonary heart disease

611

4645

1.33

9.99

1.8

1.7

0.36

0.32

mg/l

0.88

284

2177

Charcot foot

251

2.57

9.98

1.6

1.8

0.37

mg/l

0.00

127

Exposure to smoke, fire and flames

100

508

2.08

9.86

3.1

1.7

0.38

0.32

mg/l

0.39

268

Other inflammation of vagina/vulva

119

638

1.93

9.86

1.4

1.5

0.26

0.28

mg/l

0.15

257

Assault by hanging, strangulation and suffocation

4.82

9.84

2.3

1.5

0.27

0.22

mg/l

0.19

Somnolence

218

2.71

9.83

2.4

1.5

0.17

0.36

mg/l

2.41

Psoriasis (vulgaris), strict definition

130

721

1.88

9.79

2.1

1.8

0.39

0.33

mg/l

0.51

376

Major coronary heart disease event excluding revascularizations

1336

7312

1.21

9.72

1.7

0.34

0.33

mg/l

0.24

686

3719

Anosmia

131

3.07

9.69

1.4

1.3

0.23

0.36

mg/l

0.96

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1548

12531

1.19

9.66

1.7

0.29

mg/l

0.12

650

5749

Localized swelling, mass and lump of skin and subcutaneous tissue

797

6308

1.28

9.63

1.8

1.7

0.28

0.31

mg/l

0.89

369

2982

ILD, hospital admission 2, with pulmonary infections

193

1190

1.65

9.62

1.8

1.5

0.42

0.32

mg/l

1.03

532

Contusion of other and unspecified parts of foot

185

1135

1.68

9.62

2.3

1.7

0.26

0.28

mg/l

0.15

536

AV-block

330

1942

1.47

9.62

1.6

1.5

0.33

0.31

mg/l

0.27

145

889

Post-traumatic wound infection, not elsewhere classified

103

534

2.02

9.55

2.5

1.7

0.35

0.32

mg/l

0.19

267

Spondyloarthritis

474

3501

1.37

9.55

1.8

0.29

0.31

mg/l

0.51

225

1698

Recurrent dislocation of patella

182

1114

1.68

9.55

1.8

1.7

0.25

0.27

mg/l

0.30

494

Neuromuscular dysfunction of bladder

220

1406

1.60

9.52

1.6

0.24

0.32

mg/l

1.37

654

Medical treatment for female infertility

323

4559

0.69

9.51

1.7

1.6

0.32

0.28

mg/l

0.51

113

1865

Chondrocostal junction syndrome [Tietze]

110

582

1.96

9.50

2.0

1.5

0.33

0.31

mg/l

0.12

254

All dysplastic lesions of the cervix uteri

680

5205

1.30

9.49

1.8

1.6

0.27

0.28

mg/l

0.16

312

2056

Effects of foreign body entering through natural orifice

751

5922

1.29

9.48

2.0

1.9

0.29

0.32

mg/l

0.77

381

3039

Algoneurodystrophy

109

577

1.97

9.45

1.7

1.6

0.25

0.31

mg/l

0.54

266

Gonococcal infection

113

606

1.94

9.44

1.8

1.6

0.26

0.33

mg/l

0.82

288

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

232

1511

1.58

9.39

1.6

1.8

0.27

0.31

mg/l

0.45

107

726

Heterophoria

239

1564

1.57

9.39

1.7

0.30

mg/l

0.01

721

Injury of nerves at lower leg level

171

2.91

9.36

2.2

1.6

0.46

0.39

mg/l

0.25

Disorders of speech understanding and production

142

801

1.80

9.36

1.8

1.7

0.26

0.24

mg/l

0.23

361

Familial hypercholesterolemia

266

1776

1.52

9.33

1.6

0.32

0.30

mg/l

0.16

121

780

Menorrhagia

730

3166

1.30

9.27

1.5

1.6

0.24

0.30

mg/l

2.36

272

1309

Diseases of appendix

2160

16800

1.16

9.22

1.8

0.31

mg/l

0.10

1056

8189

Prolonged pregnancy

260

3272

0.67

9.21

1.4

1.6

0.29

0.27

mg/l

0.21

1313

Disorders of eyelid, lacrimal system and orbit

2257

14402

1.15

9.21

1.7

0.28

0.31

mg/l

1.62

987

6837

Polyarthrosis

367

2345

1.42

9.20

1.5

0.35

0.32

mg/l

0.37

177

1023

Carrier of infectious disease

465

2.08

9.19

2.2

1.6

0.24

0.31

mg/l

0.74

202

Sequelae of poisoning by drugs, medicaments and biological substances

6.32

9.10

1.8

1.4

0.30

0.21

mg/l

0.29

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

833

6678

1.26

9.05

1.7

0.28

0.31

mg/l

0.98

325

3109

ILD, hospital admissions

293

2010

1.48

9.03

1.7

1.6

0.38

0.32

mg/l

0.82

139

899

Hyperhidrosis

508

2.00

8.99

1.8

1.6

0.37

0.25

mg/l

0.79

227

Visual impairment including blindness (binocular or monocular)

155

921

1.72

8.99

1.5

1.7

0.36

0.31

mg/l

0.42

406

Other interstitial pulmonary diseases

295

2029

1.47

8.97

1.7

1.6

0.38

0.32

mg/l

0.85

139

903

Chronic ulcer of skin, not elsewhere classified

160

960

1.70

8.97

1.7

1.6

0.34

0.33

mg/l

0.06

450

Voice disturbances

601

4635

1.31

8.96

1.6

0.32

0.31

mg/l

0.17

216

2084

Enteropathic arthropathies

394

2.15

8.96

1.9

1.7

0.26

0.33

mg/l

0.58

188

Disorders of plasma-protein metabolism, not elsewhere classified

3.54

8.95

1.8

1.5

0.13

0.29

mg/l

—

Interstitial lung disease endpoints

295

2030

1.47

8.95

1.7

1.6

0.38

0.32

mg/l

0.84

139

908

Interstitial lung disease

295

2030

1.47

8.95

1.7

1.6

0.38

0.32

mg/l

0.84

139

908

Delivery

643

4359

0.77

8.94

1.6

1.5

0.25

0.26

mg/l

0.29

227

1671

Decubitus ulcer and pressure area

132

751

1.80

8.94

1.9

1.6

0.39

0.34

mg/l

0.31

337

Hypogonadotropic hypogonadism

144

850

1.78

8.93

2.0

1.9

0.22

0.36

mg/l

2.79

486

Parkinson's disease, excluding more controls

164

905

1.68

8.92

1.3

1.4

0.19

0.25

mg/l

1.12

385

Burn and corrosion of hip and lower limb, except ankle and foot

471

2.05

8.91

3.2

1.6

0.28

0.35

mg/l

0.93

224

Sequelae of injuries of upper limb

291

2010

1.48

8.82

2.1

1.8

0.31

0.32

mg/l

0.22

164

1010

Appendicitis, broad definition

2141

16760

1.15

8.80

1.7

1.8

0.31

mg/l

0.10

1047

8178

Other disorders of bladder

266

1802

1.50

8.79

1.6

0.25

0.32

mg/l

1.69

125

856

DVT of lower extremities

398

2898

1.39

8.78

1.8

1.6

0.32

mg/l

0.05

189

1394

Other disorders of skin and subcutaneous tissue, not elsewhere classified

330

2329

1.44

8.78

1.6

0.32

0.31

mg/l

0.15

152

1066

Other disorders of adrenal gland

134

773

1.79

8.78

1.6

1.7

0.31

0.30

mg/l

0.08

361

Allergic conjunctivitis

1612

13267

1.18

8.75

1.7

0.28

0.29

mg/l

0.30

678

6077

Conjunctivitis (acute, non atopic)

791

6306

1.26

8.73

1.8

1.7

0.27

0.30

mg/l

0.86

351

2981

Other viral diseases, not elsewhere classified

534

4060

1.33

8.73

1.8

0.26

0.30

mg/l

1.11

249

1954

Injury of nerves at forearm level

263

2.45

8.71

2.9

1.6

0.39

0.33

mg/l

0.37

126

Meralgia paraesthetica

508

1.98

8.67

1.6

0.26

0.36

mg/l

1.40

249

Toxic effect of organic solvents

3.79

8.64

2.3

1.5

0.23

0.28

mg/l

0.22

Ganglion

530

4043

1.33

8.61

1.7

0.27

0.30

mg/l

0.67

246

1885

Osteoporosis with pathological fracture (FG)

114

627

1.85

8.60

1.7

1.4

0.30

mg/l

0.04

223

Palmar fascial fibromatosis [Dupuytren]

298

2071

1.46

8.59

2.1

1.6

0.33

0.32

mg/l

0.16

165

989

Valvular heart disease excluding rheumatic fever

1017

5948

1.23

8.59

1.7

0.30

0.31

mg/l

0.21

489

2944

320

2.24

8.57

1.8

1.5

0.18

0.21

mg/l

0.12

134

Later onset COPD

419

2465

1.38

8.55

1.6

1.4

0.29

0.27

mg/l

0.29

201

1006

Histrionic personality disorder

4.11

8.51

1.9

1.3

0.27

0.39

mg/l

—

Fall involving bed

340

2.18

8.48

1.9

1.5

0.41

0.35

mg/l

0.43

137

Crohn disease (strict definition, all UC cases excluded)

173

1080

1.65

8.47

1.6

1.8

0.26

0.30

mg/l

0.42

526

Oligomenorrhoea

106

577

1.90

8.43

1.7

1.6

0.31

0.26

mg/l

0.30

235

Psoriatic arthropathies

258

1756

1.50

8.39

1.7

0.29

0.32

mg/l

0.47

144

864

Burn and corrosion of trunk

104

566

1.92

8.37

2.4

1.8

0.27

0.31

mg/l

0.41

285

Non-rheumatic valve diseases

1008

5903

1.23

8.36

1.7

0.31

mg/l

0.14

481

2917

Other nutritional anaemias

113

3.19

8.36

1.4

1.3

0.31

mg/l

0.01

Unspecified acute lower respiratory infection

430

3203

1.36

8.32

1.8

0.33

0.32

mg/l

0.14

221

1635

Lactose intolerance

502

1.96

8.30

1.8

1.6

0.30

0.29

mg/l

0.07

217

Unspecified/other endometriosis

253

1684

1.50

8.27

1.6

1.7

0.22

0.29

mg/l

1.22

688

Drug-induced obesity

148

2.92

8.25

2.1

1.4

0.22

0.25

mg/l

0.14

Toxic effect of alcohol

408

2.09

8.25

2.3

1.7

0.36

0.32

mg/l

0.20

213

Glomerular disorders in diseases classified elsewhere

294

2062

1.45

8.20

1.7

0.31

0.32

mg/l

0.12

110

1005

HSIL lesion of the cervix uteri, vagina or vulva

510

3901

1.32

8.18

1.9

1.6

0.28

mg/l

0.01

237

1527

Hypertrophy of breast in women and men

473

3581

1.34

8.16

1.6

0.25

0.30

mg/l

1.08

196

1544

Nonsuppurative otitis media, including avohilmo

1025

7336

1.22

8.14

1.7

0.24

0.27

mg/l

0.87

472

3290

Other noninflammatory disorders of vulva and perineum

228

1523

1.52

8.12

1.5

1.6

0.27

mg/l

0.08

619

Presence of other functional implants

1237

7103

1.20

8.11

1.5

1.6

0.32

mg/l

0.13

553

3424

Redundant prepuce, phimosis and paraphimosis

738

5832

1.26

8.08

2.0

0.28

0.33

mg/l

1.92

395

3334

Pyogenic arthritis

158

973

1.66

8.06

2.0

1.7

0.27

0.30

mg/l

0.36

479

Testicular dysfunction

170

1075

1.65

8.04

2.3

2.1

0.27

0.35

mg/l

1.15

632

Otitis media, unspecified

375

2531

1.39

8.04

1.6

1.7

0.19

0.25

mg/l

1.97

153

1082

Acne vulgaris

325

2331

1.42

8.02

1.7

0.23

0.25

mg/l

0.38

132

1017

Sexual assault by bodily force

4.93

8.01

3.3

1.4

0.26

0.19

mg/l

0.23

Inflammatory diseases of the central nervous system

228

1531

1.52

8.00

1.9

1.8

0.37

0.31

mg/l

0.71

109

743

Tic and related disorders

313

2.26

7.99

2.2

1.6

0.17

0.24

mg/l

0.89

136

Lactose intolerance, other/unspecified

439

2.01

7.97

1.9

1.7

0.32

0.30

mg/l

0.11

188

Syphilis, including avohilmo

498

1.95

7.92

1.5

1.8

0.29

0.35

mg/l

0.47

257

Syphilis

498

1.95

7.92

1.5

1.8

0.29

0.35

mg/l

0.47

257

HSIL lesion of the cervix uteri

476

3625

1.33

7.91

1.9

1.6

0.27

0.28

mg/l

0.12

224

1427

Enlarged lymph nodes

364

2661

1.38

7.90

1.7

1.6

0.29

mg/l

0.01

183

1208

Abnormality of red blood cells

3.50

7.89

1.6

1.5

0.20

0.33

mg/l

0.95

Adrenocortical insufficiency

105

583

1.86

7.88

1.7

1.6

0.30

0.34

mg/l

0.25

274

Intestinal adhesions without obstruction

175

1110

1.60

7.88

1.5

1.6

0.41

0.31

mg/l

0.64

492

Faecal incontinence

158

977

1.64

7.87

1.5

0.23

0.30

mg/l

0.91

407

Malignant neoplasm of bronchus and lung

162

2134

0.63

7.85

1.4

1.5

0.30

0.31

mg/l

0.10

957

Myocardial infarction

1042

6037

1.21

7.81

1.6

1.7

0.34

0.33

mg/l

0.19

526

3090

Pyothorax

114

650

1.81

7.81

2.5

1.7

0.38

0.34

mg/l

0.25

318

Hypermobility syndrome

165

1040

1.63

7.77

1.6

0.21

0.27

mg/l

0.92

433

Benign neoplasm of other and unspecified endocrine glands

313

2243

1.42

7.73

1.6

0.33

0.31

mg/l

0.18

136

1046

Injury of muscle and tendon at forearm level

377

2.10

7.73

2.5

1.6

0.35

0.32

mg/l

0.18

184

Seborrhoeic dermatitis

260

1804

1.47

7.72

1.9

1.7

0.28

0.32

mg/l

0.57

136

869

Diseases of male genital organs

1724

7498

1.17

7.70

2.0

0.29

0.33

mg/l

2.73

922

4329

Other inflammation of eyelid, including avohilmo

1291

10981

1.18

7.69

1.6

1.8

0.23

0.30

mg/l

6.25

568

5126

Parkinson's disease, strict definition, excluding more controls

149

848

1.65

7.68

1.3

0.19

0.25

mg/l

1.02

352

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2604

18057

1.13

7.64

1.7

1.8

0.29

0.30

mg/l

0.65

1145

8698

Pediculosis, acariasis and other infestations

196

1291

1.56

7.64

2.3

1.8

0.38

0.31

mg/l

0.75

104

648

Disorders of sclera, cornea, iris and ciliary body

1477

12705

1.17

7.63

1.7

1.8

0.30

0.31

mg/l

0.32

720

6116

Other injuries of spine and trunk, level unspecified

167

2.72

7.58

2.5

1.6

0.42

0.35

mg/l

0.30

Need for immunization against other single viral diseases

366

2.10

7.58

1.8

0.28

0.34

mg/l

0.51

178

Sequelae of other external causes

151

936

1.65

7.58

1.9

1.6

0.31

0.34

mg/l

0.19

444

Diabetic neuropathy

323

2329

1.41

7.57

1.7

1.8

0.32

mg/l

0.02

155

1133

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

124

734

1.75

7.54

1.6

1.7

0.33

0.30

mg/l

0.18

345

Atopic dermatitis, strict definition

934

7569

1.22

7.50

1.6

1.8

0.29

0.28

mg/l

0.34

422

3416

Cauda equina syndrome

216

2.46

7.50

2.2

1.6

0.22

0.29

mg/l

0.52

Postprocedural disorders of digestive system, not elsewhere classified

448

1.96

7.49

1.9

1.6

0.44

0.30

mg/l

0.84

203

ILD, hospital admissions 1, main diag only

255

1771

1.46

7.47

1.6

0.37

0.33

mg/l

0.49

119

787

Dermatitis due to substances taken internally

146

901

1.66

7.47

2.2

1.7

0.35

0.31

mg/l

0.29

403

Malignant neoplasm of respiratory system and intrathoracic organs

203

2501

0.67

7.44

1.5

0.32

0.31

mg/l

0.12

108

1123

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Phosphatidylethanol [Mass/volume] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS